Comparison	O
of	O
the	O
transactivation	B-protein
domains	I-protein
of	O
Stat5	B-protein
and	O
Stat6	B-protein
in	O
lymphoid	B-cell_type
cells	I-cell_type
and	O
mammary	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
.	O

Stat	B-protein
(	O
signal	B-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
)	O
and	O
Jak	B-protein
(	O
Janus	B-protein
kinases	I-protein
)	O
proteins	O
are	O
central	O
components	O
in	O
the	O
signal	O
transduction	O
events	O
in	O
hematopoietic	B-cell_type
and	I-cell_type
epithelial	I-cell_type
cells	I-cell_type
.	O

They	O
are	O
rapidly	O
activated	O
by	O
various	O
cytokines	B-protein
,	O
hormones	O
,	O
and	O
growth	O
factors	O
.	O

Upon	O
ligand	O
binding	O
and	O
cytokine	B-protein
receptor	I-protein
dimerization	O
,	O
Stat	B-protein
proteins	I-protein
are	O
phosphorylated	O
on	O
tyrosine	O
residues	O
by	O
Jak	B-protein
kinases	I-protein
.	O

Activated	O
Stat	B-protein
proteins	I-protein
form	O
homo-	O
or	O
heterodimers	O
,	O
translocate	O
to	O
the	O
nucleus	O
,	O
and	O
induce	O
transcription	O
from	O
responsive	O
genes	O
.	O

Stat5	B-protein
and	O
Stat6	B-protein
are	O
transcription	B-protein
factors	I-protein
active	O
in	O
mammary	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
and	O
immune	O
cells	O
.	O

Prolactin	O
activates	O
Stat5	B-protein
,	O
and	O
interleukin-4	B-protein
(	O
IL-4	B-protein
)	O
activates	O
Stat6	B-protein
.	O

Both	O
cytokines	B-protein
are	O
able	O
to	O
stimulate	O
cell	O
proliferation	O
,	O
differentiation	O
,	O
and	O
survival	O
.	O

We	O
investigated	O
the	O
transactivation	O
potential	O
of	O
Stat6	B-protein
and	O
found	O
that	O
it	O
is	O
not	O
restricted	O
to	O
lymphocytes	O
.	O

IL-4	B-protein
-dependent	O
activation	O
of	O
Stat6	B-protein
was	O
also	O
observed	O
in	O
HC11	B-cell_line
mammary	I-cell_line
epithelial	I-cell_line
cells	I-cell_line
.	O

In	O
these	O
cells	O
,	O
Stat6	B-protein
activation	O
led	O
to	O
the	O
induction	O
of	O
the	O
beta-casein	B-DNA
gene	I-DNA
promoter	I-DNA
.	O

The	O
induction	O
of	O
this	O
promoter	O
was	O
confirmed	O
in	O
COS7	B-cell_line
cells	I-cell_line
.	O

The	O
glucocorticoid	B-protein
receptor	I-protein
was	O
able	O
to	O
further	O
enhance	O
IL-4	B-protein
-induced	O
gene	O
transcription	O
through	O
the	O
action	O
of	O
Stat6	B-protein
.	O

Deletion	O
analysis	O
of	O
the	O
carboxyl-terminal	B-protein
region	I-protein
of	O
Stat6	B-protein
and	O
recombination	O
of	O
this	O
region	O
with	O
a	O
heterologous	B-protein
DNA	I-protein
binding	I-protein
domain	I-protein
allowed	O
the	O
delimitation	O
and	O
characterization	O
of	O
the	O
transactivation	O
domain	O
of	O
Stat6	B-protein
.	O

The	O
potencies	O
of	O
the	O
transactivation	B-protein
domains	I-protein
of	O
Stat5	B-protein
,	O
Stat6	B-protein
,	O
and	O
viral	B-protein
protein	I-protein
VP16	I-protein
were	O
compared	O
.	O

Stat6	B-protein
had	O
a	O
transactivation	O
domain	O
which	O
was	O
about	O
10-fold	O
stronger	O
than	O
that	O
of	O
Stat5	B-protein
.	O

In	O
pre-B	B-cell_type
cells	I-cell_type
(	O
Ba/F3	O
)	O
,	O
the	O
transactivation	O
domain	O
of	O
Stat6	B-protein
was	O
IL-4	B-protein
regulated	O
,	O
independently	O
from	O
its	O
DNA	O
binding	O
function	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
July	NULL
1997	NULL
,	NULL
p.	NULL
3663-3678	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

7	NULL
Comparison	NULL
of	NULL
the	NULL
Transactivation	NULL
Domains	NULL
of	NULL
Stat5	NULL
and	NULL
Stat6	NULL
in	NULL
Lymphoid	NULL
Cells	NULL
and	NULL
Mammary	NULL
Epithelial	NULL
Cells	NULL
RICHARD	NULL
MORIGGL	NULL
,	NULL
*	NULL
SUSANNE	NULL
BERCHTOLD	NULL
,	NULL
'	NULL
KARLHEINZ	NULL
FRIEDRICH	NULL
,	NULL
``	NULL
GESCHE	NULL
J.	NULL
R.	NULL
STANDKE	NULL
,	NULL
*	NULL
WINFRIED	NULL
KAMMER	NULL
,	NULL
``	NULL
MARKUS	NULL
HEIM	NULL
,	NULL
*	NULL
MANUELA	NULL
WISSLER	NULL
,	NULL
'	NULL
ELISABETH	NULL
FABRICE	NULL
GOUILLEUX	NULL
,	NULL
*	NULL
anp	NULL
BERND	NULL
GRONER	NULL
!	NULL

*	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
,	NULL
Tumor	NULL
Biology	NULL
Center	NULL
,	NULL
and	NULL
Dept	NULL
.	NULL

of	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Freiburg	NULL
,	NULL
``	NULL
and	NULL
Dept	NULL
.	NULL

of	NULL
Medicine	NULL
,	NULL
University	NULL
Hospital	NULL
Freiburg	NULL
,	NULL
``	NULL
D-79106	NULL
Freiburg	NULL
,	NULL
and	NULL
Theodor-Boveri-Institut	NULL
fiir	NULL
Biowissenschaften	NULL
(	NULL
Biozentrum	NULL
)	NULL
,	NULL
Physiologische	NULL
Chemie	NULL
II	NULL
,	NULL
97074	NULL
Wiirzburg	NULL
,	NULL
``	NULL
Germany	NULL
,	NULL
Institut	NULL
Cochin	NULL
de	NULL
Génétique	NULL
Moléculaire	NULL
,	NULL
Laboratoire	NULL
d'Oncologie	NULL
Cellulaire	NULL
et	NULL
Moléculaire	NULL
,	NULL
Unité	NULL
INSERM	NULL
U363	NULL
,	NULL
Hopital	NULL
Cochin	NULL
,	NULL
75014	NULL
Paris	NULL
,	NULL
France	NULL
,	NULL
``	NULL
and	NULL
Novartis	NULL
,	NULL
Pharma	NULL
Research	NULL
,	NULL
CH-4002	NULL
Basel	NULL
,	NULL
Switzerland	NULL
``	NULL
Received	NULL
26	NULL
November	NULL
1996/Returned	NULL
for	NULL
modification	NULL
13	NULL
January	NULL
1997/Accepted	NULL
15	NULL
April	NULL
1997	NULL
Stat	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
and	NULL
Jak	NULL
(	NULL
Janus	NULL
kinases	NULL
)	NULL
proteins	NULL
are	NULL
central	NULL
components	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
events	NULL
in	NULL
hematopoietic	NULL
and	NULL
epithelial	NULL
cells	NULL
.	NULL

They	NULL
are	NULL
rapidly	NULL
activated	NULL
by	NULL
various	NULL
cytokines	NULL
,	NULL
hormones	NULL
,	NULL
and	NULL
growth	NULL
factors	NULL
.	NULL

Upon	NULL
ligand	NULL
binding	NULL
and	NULL
cytokine	NULL
receptor	NULL
dimerization	NULL
,	NULL
Stat	NULL
proteins	NULL
are	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residues	NULL
by	NULL
Jak	NULL
kinases	NULL
.	NULL

Activated	NULL
Stat	NULL
proteins	NULL
form	NULL
homo-	NULL
or	NULL
heterodimers	NULL
,	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
induce	NULL
transcription	NULL
from	NULL
responsive	NULL
genes	NULL
.	NULL

Stat5	NULL
and	NULL
Stat6	NULL
are	NULL
transcription	NULL
factors	NULL
active	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
and	NULL
immune	NULL
cells	NULL
.	NULL

Prolactin	NULL
activates	NULL
Stat5	NULL
,	NULL
and	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
activates	NULL
Stat6	NULL
.	NULL

Both	NULL
cytokines	NULL
are	NULL
able	NULL
to	NULL
stimulate	NULL
cell	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
survival	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
Stat6	NULL
and	NULL
found	NULL
that	NULL
it	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
lymphocytes	NULL
.	NULL

IL-4-dependent	NULL
activation	NULL
of	NULL
Stat6	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
HC11	NULL
mammary	NULL
epithelial	NULL
cells	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
Stat6	NULL
activation	NULL
led	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
this	NULL
promoter	NULL
was	NULL
confirmed	NULL
in	NULL
COS7	NULL
cells	NULL
.	NULL

The	NULL
glucocorticoid	NULL
receptor	NULL
was	NULL
able	NULL
to	NULL
further	NULL
enhance	NULL
IL-4-induced	NULL
gene	NULL
transcription	NULL
through	NULL
the	NULL
action	NULL
of	NULL
Stat6	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
Stat6	NULL
and	NULL
recombination	NULL
of	NULL
this	NULL
region	NULL
with	NULL
a	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domain	NULL
allowed	NULL
the	NULL
delimitation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
Stat6	NULL
.	NULL

The	NULL
potencies	NULL
of	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
Stat5	NULL
,	NULL
Stat6	NULL
,	NULL
and	NULL
viral	NULL
protein	NULL
VP16	NULL
were	NULL
compared	NULL
.	NULL

Stat6	NULL
had	NULL
a	NULL
transactivation	NULL
domain	NULL
which	NULL
was	NULL
about	NULL
10-fold	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
Stat5	NULL
.	NULL

In	NULL
pre-B	NULL
cells	NULL
(	NULL
Ba/F3	NULL
)	NULL
,	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
Stat6	NULL
was	NULL
IL-4	NULL
regulated	NULL
,	NULL
independently	NULL
from	NULL
its	NULL
DNA	NULL
binding	NULL
function	NULL
.	NULL

Stat	NULL
proteins	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
are	NULL
transcription	NULL
factors	NULL
which	NULL
transmit	NULL
signals	NULL
from	NULL
activated	NULL
cytokine	NULL
receptors	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

They	NULL
are	NULL
tyrosine	NULL
phosphorylated	NULL
by	NULL
Jak	NULL
kinases	NULL
and	NULL
dimerize	NULL
through	NULL
their	NULL
SH2	NULL
domains	NULL
(	NULL
22	NULL
,	NULL
59	NULL
)	NULL
.	NULL

A	NULL
functional	NULL
domain	NULL
structure	NULL
of	NULL
the	NULL
Stat	NULL
proteins	NULL
has	NULL
been	NULL
established	NULL
,	NULL
and	NULL
the	NULL
regions	NULL
responsible	NULL
for	NULL
dimerization	NULL
,	NULL
specific	NULL
DNA	NULL
binding	NULL
,	NULL
and	NULL
transactivation	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
21	NULL
,	NULL
23	NULL
,	NULL
49	NULL
,	NULL
62	NULL
)	NULL
.	NULL

StatSa	NULL
,	NULL
Stat5b	NULL
,	NULL
and	NULL
Stat6	NULL
are	NULL
the	NULL
members	NULL
of	NULL
the	NULL
Stat	NULL
gene	NULL
family	NULL
(	NULL
26	NULL
)	NULL
which	NULL
have	NULL
the	NULL
highest	NULL
amino	NULL
acid	NULL
homologies	NULL
.	NULL

These	NULL
mammalian	NULL
Stat	NULL
factors	NULL
are	NULL
related	NULL
to	NULL
Marelle	NULL
,	NULL
a	NULL
recently	NULL
identified	NULL
Stat	NULL
protein	NULL
important	NULL
for	NULL
Drosophila	NULL
larval	NULL
development	NULL
(	NULL
25	NULL
,	NULL
76	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
homologies	NULL
of	NULL
Marelle	NULL
with	NULL
Stat5	NULL
and	NULL
Stat6	NULL
are	NULL
37	NULL
and	NULL
34	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

Stat5a	NULL
and	NULL
Stat5b	NULL
are	NULL
two	NULL
highly	NULL
related	NULL
genes	NULL
expressed	NULL
in	NULL
most	NULL
tissues	NULL
(	NULL
3	NULL
,	NULL
31	NULL
,	NULL
41	NULL
,	NULL
51	NULL
)	NULL
.	NULL

StatSa	NULL
was	NULL
originally	NULL
found	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
prolactin-induced	NULL
gene	NULL
transcription	NULL
in	NULL
the	NULL
mammary	NULL
gland	NULL
(	NULL
63	NULL
,	NULL
64	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Prolactin	NULL
controls	NULL
the	NULL
synthesis	NULL
of	NULL
milk	NULL
proteins	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
15	NULL
,	NULL
67	NULL
)	NULL
but	NULL
also	NULL
functions	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

It	NULL
regulates	NULL
genes	NULL
important	NULL
for	NULL
growth	NULL
and	NULL
differentiation	NULL
in	NULL
lymphocytes	NULL
(	NULL
12	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
Stat5	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
prolactin	NULL
,	NULL
and	NULL
Stat5	NULL
has	NULL
been	NULL
found	NULL
to	NULL
respond	NULL
to	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cytokines	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
,	NULL
Tumor	NULL
Biology	NULL
Center	NULL
,	NULL
Breisacher	NULL
Str	NULL
.	NULL

117	NULL
,	NULL
D-79106	NULL
Freiburg	NULL
,	NULL
Germany	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
49	NULL
)	NULL
761	NULL
2061600	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
49	NULL
)	NULL
761	NULL
206	NULL
1599	NULL
.	NULL

3663	NULL
Interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
is	NULL
an	NULL
effective	NULL
modulator	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
(	NULL
13	NULL
,	NULL
65	NULL
)	NULL
.	NULL

It	NULL
is	NULL
secreted	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
thymocytes	NULL
,	NULL
basophils	NULL
,	NULL
and	NULL
mast	NULL
cells	NULL
(	NULL
54	NULL
)	NULL
.	NULL

IL-4	NULL
acts	NULL
on	NULL
different	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
lymphocytes	NULL
,	NULL
macrophages	NULL
,	NULL
monocytes	NULL
,	NULL
dendritic	NULL
cells	NULL
,	NULL
keratinocytes	NULL
,	NULL
eosinophils	NULL
,	NULL
and	NULL
epithelial	NULL
cells	NULL
(	NULL
46	NULL
,	NULL
65	NULL
,	NULL
75	NULL
)	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
cells	NULL
involved	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
IL-4	NULL
receptor	NULL
(	NULL
IL-4R	NULL
)	NULL
leads	NULL
to	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
or	NULL
cellular	NULL
survival	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
20	NULL
,	NULL
53	NULL
,	NULL
72	NULL
)	NULL
.	NULL

In	NULL
hematopoietic	NULL
cells	NULL
,	NULL
IL-4	NULL
mediates	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
Th2	NULL
phenotype	NULL
in	NULL
T-helper	NULL
cells	NULL
(	NULL
34	NULL
,	NULL
46	NULL
)	NULL
and	NULL
the	NULL
immunoglobulin	NULL
isotype	NULL
switching	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
response	NULL
to	NULL
IL-4	NULL
is	NULL
partly	NULL
mediated	NULL
through	NULL
Stat6	NULL
.	NULL

Binding	NULL
sites	NULL
for	NULL
Stat6	NULL
were	NULL
found	NULL
to	NULL
correlate	NULL
with	NULL
phosphotyrosine	NULL
residues	NULL
574	NULL
and	NULL
611	NULL
of	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
IL-4R	NULL
a	NULL
chain	NULL
(	NULL
24	NULL
,	NULL
53	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Homodimerization	NULL
of	NULL
IL-4R	NULL
a	NULL
chains	NULL
is	NULL
sufficient	NULL
for	NULL
Jak1	NULL
and	NULL
Stat6	NULL
activation	NULL
in	NULL
Ba/F3	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
high-affinity	NULL
IL-4R	NULL
complex	NULL
of	NULL
lymphocytes	NULL
consists	NULL
of	NULL
the	NULL
IL-4R	NULL
«	NULL
chain	NULL
(	NULL
45	NULL
)	NULL
and	NULL
the	NULL
common	NULL
y	NULL
,	NULL
,	NULL
chain	NULL
,	NULL
which	NULL
is	NULL
also	NULL
a	NULL
structural	NULL
component	NULL
of	NULL
the	NULL
IL-2	NULL
,	NULL
IL-7	NULL
,	NULL
IL-9	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-15	NULL
receptors	NULL
(	NULL
33	NULL
,	NULL
37	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Human	NULL
Stat6	NULL
(	NULL
h-Stat6	NULL
)	NULL
and	NULL
mouse	NULL
Stat6	NULL
genes	NULL
have	NULL
83	NULL
%	NULL
amino	NULL
acid	NULL
identity	NULL
(	NULL
24	NULL
,	NULL
48	NULL
)	NULL
.	NULL

The	NULL
biological	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
IL-4	NULL
signalling	NULL
was	NULL
shown	NULL
in	NULL
mice	NULL
in	NULL
which	NULL
the	NULL
Stat6	NULL
gene	NULL
was	NULL
inactivated	NULL
by	NULL
homologous	NULL
recombination	NULL
(	NULL
29	NULL
,	NULL
66	NULL
,	NULL
69	NULL
)	NULL
.	NULL

Mice	NULL
deficient	NULL
in	NULL
Stat6	NULL
had	NULL
defects	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
mice	NULL
lacking	NULL
the	NULL
IL-4	NULL
gene	NULL
(	NULL
34	NULL
,	NULL
36	NULL
,	NULL
70	NULL
)	NULL
.	NULL

Deficient	NULL
mice	NULL
did	NULL
not	NULL
develop	NULL
Th2	NULL
T-helper	NULL
cells	NULL
and	NULL
had	NULL
low	NULL
surface	NULL
expression	NULL
levels	NULL
of	NULL
CD23	NULL
,	NULL
IL-4R	NULL
«	NULL
,	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
molecules	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
3664	NULL
MORIGGL	NULL
ET	NULL
AL	NULL
.	NULL

immunoglobulin	NULL
E	NULL
in	NULL
their	NULL
sera	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
mice	NULL
were	NULL
highly	NULL
susceptible	NULL
to	NULL
helminthic	NULL
parasites	NULL
.	NULL

The	NULL
carboxyl-terminal	NULL
regions	NULL
of	NULL
the	NULL
Stat	NULL
factors	NULL
show	NULL
the	NULL
most	NULL
pronounced	NULL
sequence	NULL
diversity	NULL
.	NULL

Studies	NULL
of	NULL
naturally	NULL
occurring	NULL
splice	NULL
variants	NULL
of	NULL
Stat1	NULL
,	NULL
Stat3	NULL
,	NULL
Stat5a	NULL
,	NULL
and	NULL
Stat5b	NULL
and	NULL
of	NULL
carboxyl-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
Statl	NULL
,	NULL
Stat2	NULL
,	NULL
Stat3	NULL
,	NULL
StatSa	NULL
,	NULL
and	NULL
StatSb	NULL
(	NULL
30	NULL
,	NULL
31	NULL
,	NULL
44	NULL
,	NULL
47	NULL
,	NULL
49	NULL
,	NULL
51	NULL
,	NULL
58	NULL
,	NULL
60	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
carboxyl-terminal	NULL
domain	NULL
is	NULL
essential	NULL
for	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
transactivation	NULL
potential	NULL
of	NULL
Stat6	NULL
was	NULL
tested	NULL
by	NULL
the	NULL
introduction	NULL
of	NULL
a	NULL
Stat6	NULL
response	NULL
element-containing	NULL
promoter	NULL
gene	NULL
construct	NULL
into	NULL
IL-4-responsive	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
32	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
characterized	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
Stat6	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
transactivation	NULL
.	NULL

We	NULL
compared	NULL
the	NULL
transactivation	NULL
properties	NULL
of	NULL
Stat5	NULL
and	NULL
Stat6	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
B-casein	NULL
,	NULL
cytokine	NULL
inducible	NULL
sequence	NULL
(	NULL
CIS	NULL
)	NULL
,	NULL
and	NULL
oncostatin	NULL
M	NULL
(	NULL
OSM	NULL
)	NULL
promoters	NULL
were	NULL
used	NULL
to	NULL
measure	NULL
transcriptional	NULL
induction	NULL
.	NULL

These	NULL
promoters	NULL
contain	NULL
adjacent	NULL
Stat	NULL
response	NULL
elements	NULL
(	NULL
64	NULL
,	NULL
77	NULL
,	NULL
78	NULL
)	NULL
.	NULL

Prolactin	NULL
induces	NULL
B-casein	NULL
gene	NULL
transcription	NULL
through	NULL
the	NULL
action	NULL
of	NULL
Stats	NULL
in	NULL
COS7	NULL
and	NULL
HC11	NULL
cells	NULL
.	NULL

Stat6	NULL
is	NULL
also	NULL
able	NULL
to	NULL
induce	NULL
B-casein	NULL
expression	NULL
through	NULL
binding	NULL
to	NULL
the	NULL
Stat	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
.	NULL

We	NULL
compared	NULL
the	NULL
transactivation	NULL
efficacy	NULL
of	NULL
Stat5	NULL
with	NULL
those	NULL
of	NULL
Stat6	NULL
and	NULL
the	NULL
acidic	NULL
transactivator	NULL
VP16	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
cultures	NULL
and	NULL
transfections	NULL
.	NULL

HC11	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
medium	NULL
containing	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
bovine	NULL
insulin	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
10	NULL
ng	NULL
of	NULL
murine	NULL
epidermal	NULL
growth	NULL
factor	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
were	NULL
stably	NULL
transfected	NULL
with	NULL
promoter	NULL
constructs	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Hormone	NULL
induction	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
0.1	NULL
mM	NULL
dexamethasone	NULL
(	NULL
Sigma	NULL
)	NULL
and/or	NULL
5	NULL
pg	NULL
of	NULL
ovine	NULL
prolactin	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
epidermal	NULL
growth	NULL
factor	NULL
in	NULL
competent	NULL
cultures	NULL
.	NULL

HC11	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
5	NULL
%	NULL
culture	NULL
supernatant	NULL
of	NULL
murine	NULL
IL-4-overproducing	NULL
cells	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
and	NULL
were	NULL
transfected	NULL
and	NULL
induced	NULL
as	NULL
described	NULL
previously	NULL
with	NULL
prolactin	NULL
(	NULL
16	NULL
)	NULL
or	NULL
100	NULL
U	NULL
of	NULL
human	NULL
IL-4	NULL
per	NULL
ml	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
GR	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
10~	NULL
'	NULL
M	NULL
dexamethasone	NULL
treatment	NULL
for	NULL
16	NULL
h	NULL
as	NULL
previously	NULL
published	NULL
(	NULL
68	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
pre-B-cell	NULL
line	NULL
Ba/F3	NULL
,	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
prolactin	NULL
receptor	NULL
(	NULL
12	NULL
)	NULL
,	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
medium	NULL
containing	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
10	NULL
ng	NULL
of	NULL
ovine	NULL
prolactin	NULL
per	NULL
ml	NULL
.	NULL

Ba/F3	NULL
cells	NULL
,	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
human	NULL
IL4R	NULL
«	NULL
and	NULL
y	NULL
chains	NULL
,	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
medium	NULL
containing	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
5	NULL
%	NULL
culture	NULL
supernatant	NULL
of	NULL
murine	NULL
IL-3-overproducing	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Before	NULL
induction	NULL
with	NULL
ovine	NULL
prolactin	NULL
or	NULL
human	NULL
IL-4	NULL
,	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
with	NULL
3	NULL
%	NULL
horse	NULL
serum	NULL
for	NULL
3	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
prolactin	NULL
per	NULL
ml	NULL
or	NULL
100	NULL
U	NULL
of	NULL
IL-4	NULL
per	NULL
ml	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
,	NULL
luciferase	NULL
,	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
were	NULL
measured	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
67	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
expression	NULL
vector	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
luciferase	NULL
constructs	NULL
,	NULL
and	NULL
1	NULL
mg	NULL
of	NULL
pCH110	NULL
were	NULL
used	NULL
in	NULL
transfection	NULL
experiments	NULL
.	NULL

Ba/F3	NULL
cells	NULL
(	NULL
6	NULL
X	NULL
10°	NULL
)	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
prolactin	NULL
receptor	NULL
or	NULL
human	NULL
IL-4R	NULL
chains	NULL
were	NULL
electroporated	NULL
for	NULL
cach	NULL
point	NULL
with	NULL
a	NULL
Bio-Rad	NULL
gene	NULL
pulser	NULL
at	NULL
250	NULL
V/960	NULL
pF	NULL
.	NULL

Electroporated	NULL
Ba/F3	NULL
cells	NULL
were	NULL
first	NULL
cultured	NULL
in	NULL
growth	NULL
medium	NULL
,	NULL
and	NULL
4	NULL
h	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
unstimulated	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Stimulated	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
prolactin	NULL
or	NULL
IL-4	NULL
.	NULL

Ba/F3	NULL
cells	NULL
have	NULL
high	NULL
levels	NULL
of	NULL
endogenous	NULL
B-galactosidase	NULL
;	NULL
therefore	NULL
,	NULL
the	NULL
total	NULL
protein	NULL
amount	NULL
was	NULL
measured	NULL
for	NULL
normalization	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
electroporated	NULL
cells	NULL
were	NULL
harvested	NULL
.	NULL

Plasmids	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Stat5	NULL
,	NULL
Stat6	NULL
,	NULL
GR	NULL
,	NULL
cytokine	NULL
receptor	NULL
chain	NULL
,	NULL
and	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
.	NULL

The	NULL
reporter	NULL
gene	NULL
constructs	NULL
containing	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
(	NULL
-344	NULL
to	NULL
-1	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
or	NULL
the	NULL
luciferase	NULL
gene	NULL
have	NULL
previously	NULL
been	NULL
described	NULL
(	NULL
10	NULL
,	NULL
71	NULL
)	NULL
,	NULL
as	NULL
have	NULL
the	NULL
expression	NULL
vectors	NULL
for	NULL
mammary	NULL
gland	NULL
factor	NULL
(	NULL
MGF	NULL
)	NULL
-Stata	NULL
(	NULL
pXM-MGF	NULL
)	NULL
,	NULL
human	NULL
GR	NULL
(	NULL
pRSVhGRa	NULL
)	NULL
,	NULL
and	NULL
the	NULL
long	NULL
form	NULL
of	NULL
the	NULL
murine	NULL
prolactin	NULL
receptor	NULL
(	NULL
44	NULL
,	NULL
68	NULL
,	NULL
71	NULL
)	NULL
.	NULL

pCH110	NULL
encodes	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
.	NULL

The	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
human	NULL
IL-4R	NULL
«	NULL
and	NULL
y	NULL
,	NULL
,	NULL
chains	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
for	NULL
h-Stat6	NULL
(	NULL
pXM-Stat6	NULL
)	NULL
was	NULL
subcloned	NULL
as	NULL
an	NULL
EcoRI-KpnI	NULL
fragment	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
the	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
between	NULL
the	NULL
unique	NULL
EcoRI	NULL
and	NULL
Nhel	NULL
sites	NULL
was	NULL
deleted	NULL
.	NULL

The	NULL
construct	NULL
encoding	NULL
h-Stat6A677	NULL
was	NULL
derived	NULL
by	NULL
deletion	NULL
of	NULL
the	NULL
region	NULL
between	NULL
the	NULL
unique	NULL
SacI	NULL
(	NULL
nucleotide	NULL
1978	NULL
)	NULL
and	NULL
Xhol	NULL
(	NULL
adjacent	NULL
to	NULL
the	NULL
KpnI	NULL
site	NULL
within	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
)	NULL
sites	NULL
of	NULL
pXM-Stat6	NULL
and	NULL
ligation	NULL
to	NULL
a	NULL
PCR-generated	NULL
fragment	NULL
cut	NULL
with	NULL
Secl	NULL
and	NULL
Xhol	NULL
.	NULL

The	NULL
PCR-generated	NULL
fragment	NULL
was	NULL
generated	NULL
with	NULL
an	NULL
upper	NULL
primer	NULL
which	NULL
comprised	NULL
nucleotides	NULL
1912	NULL
to	NULL
1930	NULL
and	NULL
a	NULL
lower	NULL
primer	NULL
which	NULL
comprised	NULL
a	NULL
unique	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Xhol	NULL
site	NULL
for	NULL
h-Stat6A677	NULL
introduced	NULL
adjacent	NULL
to	NULL
the	NULL
stop	NULL
codon	NULL
(	NULL
nucleotides	NULL
2029	NULL
to	NULL
2031	NULL
[	NULL
gat-tgal	NULL
)	NULL
.	NULL

The	NULL
minimal	NULL
promoter	NULL
construct	NULL
N3	NULL
(	NULL
Stat-RE	NULL
)	NULL
6-tk-lue	NULL
was	NULL
described	NULL
previously	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
multimerized	NULL
Stat6	NULL
response	NULL
element	NULL
N4	NULL
(	NULL
Stat-RE	NULL
)	NULL
3	NULL
from	NULL
the	NULL
immunoglobulin	NULL
germ	NULL
line	NULL
heavy-chain	NULL
£	NULL
promoter	NULL
was	NULL
subcloned	NULL
from	NULL
a	NULL
CAT	NULL
vector	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Albert	NULL
Duschl	NULL
)	NULL
as	NULL
a	NULL
SphI-Xbal	NULL
fragment	NULL
,	NULL
which	NULL
was	NULL
subcloned	NULL
in	NULL
front	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
minimal	NULL
promoter	NULL
driving	NULL
the	NULL
luciferase	NULL
gene	NULL
.	NULL

N4	NULL
(	NULL
Stat-RE	NULL
)	NULL
3	NULL
comprises	NULL
the	NULL
following	NULL
sequence	NULL
:	NULL
5'-CATCGA	NULL
CTTCCCAAGAACAGAATCGACTTCCCAAGAACAGAATCGACTTCCC	NULL
AAGAACAGT-3	NULL
'	NULL
and	NULL
3'-GTACGTAGCTGAAGGGTTCTTGTCTTAGCTG	NULL
AAGGGTTCTTGTCTTAGCTGAAGGGTTCTTGTCAGATC-5	NULL
'	NULL
.	NULL

The	NULL
reporter	NULL
gene	NULL
constructs	NULL
containing	NULL
the	NULL
murine	NULL
OSM	NULL
gene	NULL
promoter	NULL
(	NULL
-662	NULL
to	NULL
+48	NULL
)	NULL
or	NULL
the	NULL
CIS	NULL
gene	NULL
promoter	NULL
(	NULL
-646	NULL
to	NULL
-1	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
A.	NULL
Miyajima	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
have	NULL
partly	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
77	NULL
,	NULL
78	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
constructs	NULL
.	NULL

Expression	NULL
vectors	NULL
for	NULL
GAL4	NULL
,	NULL
GALA-VP16	NULL
,	NULL
and	NULL
(	NULL
GALA	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
R.	NULL
Schiile	NULL
(	NULL
Freiburg	NULL
,	NULL
Ger-many	NULL
)	NULL
.	NULL

The	NULL
GAL4-Stat5a-722-794	NULL
construct	NULL
was	NULL
described	NULL
previously	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Stat6	NULL
carboxyl-terminal	NULL
fragments	NULL
were	NULL
PCR	NULL
generated	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
expression	NULL
vector	NULL
encoding	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GALA	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
147	NULL
)	NULL
(	NULL
56	NULL
)	NULL
.	NULL

cDNA	NULL
fragments	NULL
of	NULL
h-Staté	NULL
were	NULL
PCR	NULL
generated	NULL
with	NULL
downstream	NULL
primers	NULL
comprising	NULL
a	NULL
unique	NULL
EcoRI	NULL
site	NULL
and	NULL
upstream	NULL
primers	NULL
comprising	NULL
unique	NULL
BamHI	NULL
sites	NULL
flanking	NULL
amino	NULL
acid	NULL
positions	NULL
642	NULL
to	NULL
847	NULL
,	NULL
677	NULL
to	NULL
847	NULL
,	NULL
705	NULL
to	NULL
847	NULL
,	NULL
754	NULL
to	NULL
847	NULL
,	NULL
792	NULL
to	NULL
847	NULL
,	NULL
677	NULL
to	NULL
791	NULL
,	NULL
677	NULL
to	NULL
704	NULL
,	NULL
and	NULL
754	NULL
to	NULL
791	NULL
.	NULL

The	NULL
GALA-VP16	NULL
construct	NULL
contained	NULL
amino	NULL
acids	NULL
411	NULL
to	NULL
489	NULL
of	NULL
VP16	NULL
(	NULL
55	NULL
)	NULL
.	NULL

(	NULL
iil	NULL
)	NULL
Stat5-Stat6	NULL
transactivation	NULL
domain	NULL
chimeras	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
for	NULL
MGF-StatSaA750	NULL
(	NULL
44	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
basis	NULL
for	NULL
Stat5-Stat6	NULL
transactivation	NULL
domain	NULL
chimeras	NULL
.	NULL

A	NULL
PCR	NULL
fragment	NULL
was	NULL
created	NULL
to	NULL
introduce	NULL
a	NULL
unique	NULL
EcoRI	NULL
site	NULL
at	NULL
amino	NULL
acid	NULL
750	NULL
.	NULL

The	NULL
PCR	NULL
fragment	NULL
was	NULL
generated	NULL
with	NULL
an	NULL
upper	NULL
primer	NULL
which	NULL
comprised	NULL
nucleotides	NULL
1825	NULL
to	NULL
1847	NULL
and	NULL
a	NULL
lower	NULL
primer	NULL
which	NULL
comprised	NULL
a	NULL
unique	NULL
EcoRI	NULL
site	NULL
adjacent	NULL
to	NULL
amino	NULL
acid	NULL
750	NULL
of	NULL
MGF-Stat5	NULL
.	NULL

The	NULL
PCR	NULL
fragment	NULL
was	NULL
subcloned	NULL
as	NULL
a	NULL
KpnI	NULL
(	NULL
nucleotide	NULL
1837	NULL
)	NULL
-EcoRI	NULL
fragment	NULL
into	NULL
pXM-StatSaA750	NULL
and	NULL
ligated	NULL
with	NULL
the	NULL
PCR-generated	NULL
GALA	NULL
fusion	NULL
proteins	NULL
described	NULL
above	NULL
,	NULL
each	NULL
of	NULL
which	NULL
contained	NULL
a	NULL
unique	NULL
EcoRI	NULL
site	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
and	NULL
a	NULL
unique	NULL
BamHI	NULL
site	NULL
adjacent	NULL
to	NULL
the	NULL
stop	NULL
codon	NULL
.	NULL

The	NULL
correct	NULL
nucleotide	NULL
sequences	NULL
of	NULL
PCR	NULL
products	NULL
and	NULL
cloning	NULL
junctions	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
with	NULL
a	NULL
dideoxy	NULL
T7	NULL
DNA	NULL
sequencing	NULL
kit	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Antibodies	NULL
and	NULL
immunoblotting	NULL
analysis	NULL
.	NULL

Antisera	NULL
directed	NULL
against	NULL
the	NULL
carboxyl-terminal	NULL
domain	NULL
of	NULL
Stat6	NULL
(	NULL
amino	NULL
acid	NULL
positions	NULL
633	NULL
to	NULL
837	NULL
)	NULL
were	NULL
generated	NULL
in	NULL
rabbits	NULL
and	NULL
chickens	NULL
.	NULL

These	NULL
antisera	NULL
were	NULL
used	NULL
in	NULL
supershift	NULL
experiments	NULL
and	NULL
tested	NULL
against	NULL
all	NULL
recombinant	NULL
Stat	NULL
proteins	NULL
.	NULL

They	NULL
recognized	NULL
specifically	NULL
Stat6	NULL
from	NULL
mice	NULL
,	NULL
rats	NULL
,	NULL
and	NULL
humans	NULL
.	NULL

The	NULL
antiserum	NULL
against	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
mouse	NULL
Stat6	NULL
(	NULL
amino	NULL
acid	NULL
positions	NULL
523	NULL
to	NULL
659	NULL
)	NULL
was	NULL
generated	NULL
in	NULL
rabbits	NULL
and	NULL
has	NULL
no	NULL
cross-reactivity	NULL
to	NULL
any	NULL
other	NULL
Stat	NULL
family	NULL
member	NULL
.	NULL

Protein	NULL
fragments	NULL
were	NULL
produced	NULL
in	NULL
bacteria	NULL
as	NULL
maltose-binding	NULL
protein	NULL
fusion	NULL
proteins	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
protocol	NULL
.	NULL

The	NULL
phosphotyrosine-specific	NULL
antibody	NULL
(	NULL
PY20	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
.	NULL

A	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
,	NULL
directed	NULL
against	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GALA	NULL
,	NULL
was	NULL
used	NULL
for	NULL
supershift	NULL
experiments	NULL
to	NULL
detect	NULL
GAL4-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
polyclonal	NULL
chicken	NULL
antiserum	NULL
against	NULL
the	NULL
N-terminal	NULL
portion	NULL
of	NULL
MGF-StatSa	NULL
was	NULL
previously	NULL
described	NULL
(	NULL
71	NULL
)	NULL
.	NULL

The	NULL
polyclonal	NULL
rabbit	NULL
antiserum	NULL
against	NULL
the	NULL
B-casein	NULL
protein	NULL
was	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Immunoreactive	NULL
bands	NULL
were	NULL
visualized	NULL
with	NULL
an	NULL
epichemiluminescence	NULL
Western	NULL
blotting	NULL
system	NULL
(	NULL
Amersham	NULL
,	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Preparation	NULL
of	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

For	NULL
cytosolic	NULL
extracts	NULL
from	NULL
cell	NULL
culture	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
scraped	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
hypotonic	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
5	NULL
mg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
pg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
by	NULL
20	NULL
strokes	NULL
in	NULL
a	NULL
glass	NULL
Dounce	NULL
homogenizer	NULL
.	NULL

The	NULL
extract	NULL
was	NULL
centrifuged	NULL
for	NULL
5	NULL
min	NULL
at	NULL
2,000	NULL
x	NULL
g	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
used	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
for	NULL
bandshift	NULL
and	NULL
Western	NULL
blotting	NULL
were	NULL
prepared	NULL
by	NULL
suspension	NULL
of	NULL
cell	NULL
pellets	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
5	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
M	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
and	NULL
20	NULL
pM	NULL
phenyl	NULL
arsine	NULL
oxide	NULL
.	NULL

Freeze-thawing	NULL
was	NULL
repeated	NULL
three	NULL
times	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
centrifuged	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
20,800	NULL
x	NULL
g.	NULL
The	NULL
supernatants	NULL
were	NULL
recovered	NULL
for	NULL
bandshift	NULL
and	NULL
Western	NULL
blotting	NULL
experiments	NULL
.	NULL

The	NULL
protocol	NULL
for	NULL
bandshift	NULL
assays	NULL
has	NULL
previously	NULL
been	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
bandshift	NULL
experiments	NULL
,	NULL
the	NULL
MGF-Stat5	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
bovine	NULL
B-casein	NULL
promoter	NULL
,	NULL
5'-AGATITCTA	NULL
GGAATTCAAATC-3	NULL
'	NULL
,	NULL
was	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

This	NULL
oligonucleotide	NULL
was	NULL
end	NULL
labelled	NULL
with	NULL
polynucleotide	NULL
kinase	NULL
to	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
8,000	NULL
cpm/fmol	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
oligonucleotide	NULL
used	NULL
to	NULL
detect	NULL
GAL4-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
(	NULL
the	NULL
GAL4	NULL
binding	NULL
motif	NULL
is	NULL
underlined	NULL
)	NULL
.	NULL

This	NULL
oligonucleotide	NULL
was	NULL
labelled	NULL
with	NULL
Kienow	NULL
enzyme	NULL
to	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
8,000	NULL
epm/fmol	NULL
.	NULL

A	NULL
double-stranded	NULL
annealed	NULL
oligonucleotide	NULL
with	NULL
AT	NULL
overhangs	NULL
,	NULL
5-TATGTACCCCTACGACGT	NULL
CCCCGACTACGCCTCAGG-3	NULL
'	NULL
,	NULL
was	NULL
used	NULL
at	NULL
0.05	NULL
ug/pul	NULL
to	NULL
block	NULL
unspecific	NULL
binding	NULL
and	NULL
to	NULL
detect	NULL
GAL4-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Sequence	NULL
comparison	NULL
.	NULL

Sequence	NULL
alignments	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
PILEUP	NULL
from	NULL
the	NULL
Wisconsin	NULL
package	NULL
of	NULL
the	NULL
Genetics	NULL
Computer	NULL
Group	NULL
(	NULL
Version	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
Alls	NULL
if	NULL
-	NULL
+Prl	NULL
Pri	NULL
IL-4	NULL
incoln	NULL
Nue	NULL
teman	NULL
:	NULL
X	NULL
AkDa	NULL
_	NULL
1L-4	NULL
+Pri	NULL
Dex	NULL
Pr	NULL
-4a3	NULL
|-28	NULL
C	NULL
#	NULL
|-	NULL
1	NULL
8	NULL
<	NULL
»	NULL
I	NULL
tltl2al'24	NULL
1	NULL
C	NULL
-A	NULL
<	NULL
-Stat6-supershift	NULL
<	NULL
4-Stat6-complex	NULL
#	NULL
<	NULL
4-Stat5-complex	NULL
IL-4|	NULL
-	NULL
|	NULL
+	NULL
]	NULL
+	NULL
]	NULL
-	NULL
|	NULL
Pril	NULL
-	NULL
|	NULL
-	NULL
|-	NULL
|	NULL
+	NULL
]	NULL
}	NULL
+	NULL
«	NULL
-State	NULL
||	NULL
<	NULL
1	NULL
Z	NULL
!	NULL

1	NULL
-I	NULL
-IT	NULL
«	NULL
-Stats	NULL
l=	NULL
!	NULL

!	NULL

:	NULL
1	NULL
-IT	NULL
-	NULL
4	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Lactogenic-hormone	NULL
induction	NULL
of	NULL
Stat5	NULL
and	NULL
IL-4	NULL
induction	NULL
of	NULL
Staté	NULL
activate	NULL
B-casein	NULL
gene	NULL
transcription	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HC11	NULL
mammary	NULL
epithelial	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
no	NULL
hormones	NULL
(	NULL
-	NULL
;	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
dexamethasone	NULL
,	NULL
and	NULL
prolactin	NULL
(	NULL
Dex	NULL
+	NULL
PrI	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
prolactin	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
IL-4	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Whole-cell	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
separated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
a	NULL
mouse	NULL
B-cascin-specific	NULL
antiserum	NULL
.	NULL

The	NULL
arrow	NULL
and	NULL
horizontal	NULL
lines	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
differently	NULL
phosphorylated	NULL
forms	NULL
of	NULL
B-casein	NULL
.	NULL

(	NULL
B	NULL
)	NULL
HC11	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
B-casein	NULL
promoter-CAT	NULL
construct	NULL
were	NULL
treated	NULL
with	NULL
IL-4	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
dexamethasone	NULL
and	NULL
prolactin	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
dexamethasone	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
prolactin	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Four	NULL
independent	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
,	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Bandshift	NULL
assays	NULL
of	NULL
Stat6	NULL
activated	NULL
(	NULL
+	NULL
)	NULL
by	NULL
IL-4	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
Stat5	NULL
activated	NULL
by	NULL
prolactin	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
introduced	NULL
in	NULL
bandshift	NULL
assays	NULL
.	NULL

The	NULL
proximal	NULL
B-cascin	NULL
promoter	NULL
Stat	NULL
binding	NULL
site	NULL
served	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

Supershifts	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
(	NULL
+	NULL
)	NULL
a	NULL
polyclonal	NULL
antiserum	NULL
directed	NULL
against	NULL
Stat6	NULL
(	NULL
633	NULL
to	NULL
837	NULL
)	NULL
(	NULL
a-Stat6	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
Stat5	NULL
(	NULL
«	NULL
-Stat5	NULL
;	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

8.1	NULL
)	NULL
.	NULL

Sequences	NULL
with	NULL
the	NULL
following	NULL
GenBank	NULL
accession	NULL
numbers	NULL
were	NULL
used	NULL
:	NULL
h-Stat6	NULL
,	NULL
A54740	NULL
;	NULL
murine	NULL
Stat6	NULL
,	NULL
L47650	NULL
;	NULL
murine	NULL
OSM	NULL
,	NULL
D31942	NULL
;	NULL
and	NULL
murine	NULL
CIS	NULL
,	NULL
D31943	NULL
.	NULL

RESULTS	NULL
B-Casein	NULL
gene	NULL
transcription	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
is	NULL
induced	NULL
by	NULL
lactogenic	NULL
hormones	NULL
via	NULL
Stat5	NULL
or	NULL
by	NULL
IL-4	NULL
via	NULL
Stat6	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
milk	NULL
protein	NULL
expression	NULL
in	NULL
the	NULL
cultured	NULL
mammary	NULL
epithelial	NULL
cell	NULL
line	NULL
HC11	NULL
(	NULL
4	NULL
)	NULL
requires	NULL
the	NULL
synergistic	NULL
action	NULL
of	NULL
lactogenic	NULL
hormones	NULL
,	NULL
glucocorticoids	NULL
,	NULL
prolactin	NULL
,	NULL
and	NULL
insulin	NULL
(	NULL
4	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Prolactin	NULL
contributes	NULL
through	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
Stat5	NULL
,	NULL
and	NULL
glucocorticoid	NULL
contributes	NULL
hormone	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
GR	NULL
.	NULL

Stat5	NULL
and	NULL
the	NULL
GR	NULL
act	NULL
synergistically	NULL
in	NULL
efficient	NULL
induction	NULL
of	NULL
transcription	NULL
(	NULL
68	NULL
)	NULL
.	NULL

We	NULL
analyzed	NULL
B-casein	NULL
gene	NULL
expression	NULL
in	NULL
HC11	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
insulin	NULL
and	NULL
induced	NULL
with	NULL
prolactin	NULL
and	NULL
glucocorticoids	NULL
.	NULL

Cytosolic	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
induced	NULL
cells	NULL
and	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
B-casein	NULL
was	NULL
visualized	NULL
TRANSACTIVATION	NULL
DOMAINS	NULL
OF	NULL
Stat	NULL
FACTORS	NULL
-	NULL
3665	NULL
with	NULL
a	NULL
specific	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
doublet	NULL
around	NULL
24	NULL
kDa	NULL
is	NULL
characteristic	NULL
for	NULL
the	NULL
differentially	NULL
phosphorylated	NULL
forms	NULL
of	NULL
B-casein	NULL
in	NULL
HC11	NULL
cells	NULL
.	NULL

The	NULL
faster-migrating	NULL
band	NULL
represents	NULL
a	NULL
dexamethasone-inducible	NULL
milk	NULL
protein	NULL
which	NULL
is	NULL
also	NULL
recognized	NULL
by	NULL
the	NULL
antiserum	NULL
used	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
B-casein	NULL
expression	NULL
occurs	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

HC11	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
B-casein	NULL
promoter-CAT	NULL
construct	NULL
were	NULL
efficiently	NULL
induced	NULL
only	NULL
by	NULL
dexamethasone	NULL
and	NULL
prolactin	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
not	NULL
by	NULL
prolactin	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
dexamethasone	NULL
alone	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
region	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
comprises	NULL
the	NULL
sequences	NULL
-344	NULL
to	NULL
-1	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

This	NULL
region	NULL
includes	NULL
two	NULL
recognition	NULL
elements	NULL
of	NULL
dyad	NULL
symmetry	NULL
that	NULL
are	NULL
indicative	NULL
of	NULL
Stat	NULL
protein	NULL
binding	NULL
(	NULL
TTC-GAA	NULL
)	NULL
.	NULL

One	NULL
element	NULL
is	NULL
located	NULL
between	NULL
-144	NULL
and	NULL
-134	NULL
;	NULL
its	NULL
sequence	NULL
is	NULL
5'-TTCTTGGGAA-3	NULL
'	NULL
.	NULL

The	NULL
second	NULL
element	NULL
is	NULL
located	NULL
between	NULL
-97	NULL
and	NULL
-89	NULL
;	NULL
its	NULL
sequence	NULL
is	NULL
5'-TTCTITTGG	NULL
AA-3	NULL
'	NULL
.	NULL

Both	NULL
elements	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
Stat5	NULL
;	NULL
the	NULL
upstream	NULL
element	NULL
has	NULL
a	NULL
lower	NULL
affinity	NULL
(	NULL
63	NULL
)	NULL
.	NULL

A	NULL
comparative	NULL
analysis	NULL
of	NULL
Stat	NULL
proteins	NULL
showed	NULL
that	NULL
Stat6	NULL
binding	NULL
to	NULL
DNA	NULL
was	NULL
favored	NULL
when	NULL
the	NULL
symmetric	NULL
half	NULL
sites	NULL
were	NULL
separated	NULL
by	NULL
4	NULL
nucleotides	NULL
(	NULL
62	NULL
)	NULL
,	NULL
as	NULL
found	NULL
in	NULL
the	NULL
distal	NULL
element	NULL
.	NULL

The	NULL
inducibility	NULL
of	NULL
B-casein	NULL
in	NULL
some	NULL
cytotoxic	NULL
T-cell	NULL
lines	NULL
by	NULL
IL-4	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
found	NULL
a	NULL
functional	NULL
IL-4R	NULL
complex	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
led	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
Stat6	NULL
in	NULL
HC11	NULL
cells	NULL
.	NULL

B-Casein	NULL
was	NULL
induced	NULL
by	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
this	NULL
induction	NULL
was	NULL
transcriptional	NULL
and	NULL
conferred	NULL
by	NULL
the	NULL
-344-to	NULL
--	NULL
1	NULL
promoter	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Glucocorticoid	NULL
hormone	NULL
was	NULL
not	NULL
required	NULL
.	NULL

The	NULL
extents	NULL
of	NULL
induction	NULL
of	NULL
the	NULL
endogenous	NULL
B-casein	NULL
gene	NULL
and	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
construct	NULL
by	NULL
IL-4	NULL
or	NULL
prolactin	NULL
and	NULL
glucocorticoid	NULL
hormone	NULL
were	NULL
similar	NULL
.	NULL

Bandshift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
to	NULL
investigate	NULL
the	NULL
ability	NULL
of	NULL
Stat6	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
Stat	NULL
response	NULL
elements	NULL
found	NULL
in	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
.	NULL

When	NULL
the	NULL
proximal	NULL
binding	NULL
element	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
Stat5	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Stat6	NULL
,	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
sequence	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
HC11	NULL
cells	NULL
induced	NULL
with	NULL
IL-4	NULL
formed	NULL
a	NULL
specific	NULL
DNA	NULL
complex	NULL
with	NULL
the	NULL
radioactive	NULL
DNA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
contains	NULL
Stat6	NULL
,	NULL
since	NULL
it	NULL
can	NULL
be	NULL
supershifted	NULL
with	NULL
a	NULL
Staté6-specific	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Stat5	NULL
induced	NULL
by	NULL
prolactin	NULL
was	NULL
also	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
as	NULL
shown	NULL
previously	NULL
(	NULL
15	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Stat6	NULL
from	NULL
HC11	NULL
cells	NULL
activated	NULL
by	NULL
IL-4	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
&	NULL
response	NULL
element	NULL
and	NULL
the	NULL
B-casein	NULL
promoter-proximal	NULL
element	NULL
equally	NULL
well	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-4-induced	NULL
transcription	NULL
of	NULL
the	NULL
BB-casein	NULL
gene	NULL
promoter	NULL
in	NULL
transfected	NULL
COS7	NULL
cells	NULL
.	NULL

To	NULL
further	NULL
study	NULL
IL-4	NULL
activation	NULL
of	NULL
Stat6	NULL
and	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
this	NULL
factor	NULL
,	NULL
transient-transfection	NULL
experiments	NULL
with	NULL
COS7	NULL
cells	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

These	NULL
cells	NULL
do	NULL
not	NULL
endogenously	NULL
express	NULL
Stat6	NULL
but	NULL
contribute	NULL
all	NULL
the	NULL
components	NULL
necessary	NULL
for	NULL
IL-4	NULL
signalling	NULL
upon	NULL
provision	NULL
of	NULL
Stat6	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
to	NULL
study	NULL
Stat6	NULL
variants	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
wild-type	NULL
molecule	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
used	NULL
this	NULL
approach	NULL
to	NULL
study	NULL
prolactin	NULL
action	NULL
and	NULL
Stat5	NULL
function	NULL
(	NULL
15	NULL
,	NULL
44	NULL
)	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
IL-4R	NULL
«	NULL
and	NULL
y	NULL
,	NULL
,	NULL
chains	NULL
,	NULL
wild-type	NULL
h-Stat6	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
and	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter-luciferase	NULL
reporter	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
transiently	NULL
transfected	NULL
COS7	NULL
cells	NULL
with	NULL
IL-4	NULL
resulted	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
h-Stat6	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
h-Stat6	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
and	NULL
specific	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
molecule	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
which	NULL
can	NULL
be	NULL
supershifted	NULL
by	NULL
Stat6-specific	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
induction	NULL
(	NULL
eightfold	NULL
)	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
3666	NULL
MORIGGL	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
+	NULL
+	NULL
o-State	NULL
(	NULL
633-837	NULL
)	NULL
[	NULL
-	NULL
|-	NULL
|	NULL
+	NULL
[	NULL
-	NULL
|-	NULL
|	NULL
+	NULL
3	NULL
6	NULL
B	NULL
Blot	NULL
:	NULL
c-PY20	NULL
h-State	NULL
-	NULL
»	NULL
Maka	NULL
-	NULL
O	NULL
h-Stat6a677-	NULL
#	NULL
»	NULL
aman	NULL
Blot	NULL
:	NULL
co-Stat6	NULL
(	NULL
523-659	NULL
)	NULL
h-Stat6	NULL
-p	NULL
|	NULL
«	NULL
«	NULL
»	NULL
aam	NULL
h-Stat6aA677-	NULL
#	NULL
cad	NULL
h-IL-4	NULL
[	NULL
-	NULL
[	NULL
+	NULL
|	NULL
-	NULL
|	NULL
+	NULL
1	NULL
21134	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

C	NULL
h-Stat6	NULL
__	NULL
h-Stat6A677	NULL
-rf	NULL
h-IL-4|	NULL
-	NULL
|	NULL
+	NULL
D	NULL
(	NULL
s-casein-pro	NULL
.	NULL
)	NULL

-344	NULL
-1440-134-97	NULL
-	NULL
-89	NULL
-1	NULL
-	NULL
>	NULL
0	NULL
N	NULL
rel	NULL
.	NULL

luciferase	NULL
activit	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
ab	NULL
h-Stat6	NULL
h-Stat6A677	NULL
hIL-4Ro+ye|	NULL
+	NULL
|	NULL
+	NULL
|	NULL
+	NULL
|	NULL
+	NULL
|	NULL
+	NULL
|	NULL
+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Stat6	NULL
activation	NULL
and	NULL
B-casein	NULL
promoter-luciferase	NULL
induction	NULL
by	NULL
IL-4	NULL
in	NULL
transfected	NULL
COS7	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Structures	NULL
of	NULL
human-Stat6	NULL
and	NULL
the	NULL
carboxyl-terminal	NULL
deletion	NULL
mutant	NULL
h-Stat6A677	NULL
.	NULL

Amino	NULL
acid	NULL
(	NULL
aa	NULL
)	NULL
positions	NULL
,	NULL
the	NULL
SH2	NULL
domain	NULL
,	NULL
and	NULL
the	NULL
cytokine-dependent	NULL
phosphorylation	NULL
site	NULL
(	NULL
Y	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
COS7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
h-Stat6	NULL
,	NULL
h-Stat6A677	NULL
,	NULL
IL-4R	NULL
a	NULL
and	NULL
y	NULL
,	NULL
,	NULL
chains	NULL
,	NULL
a	NULL
B-casein-luciferase	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
.	NULL

Cells	NULL
were	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
IL-4	NULL
for	NULL
1	NULL
h.	NULL
Extracts	NULL
were	NULL
prepared	NULL
and	NULL
separated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
h-Stat6	NULL
and	NULL
h-Stat6A677	NULL
was	NULL
probed	NULL
with	NULL
tyrosine	NULL
phosphate-specific	NULL
antiserum	NULL
(	NULL
a-PY20	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
h-Stat6	NULL
and	NULL
h-Stat6A677	NULL
was	NULL
determined	NULL
with	NULL
Staté-specific	NULL
antiserum	NULL
[	NULL
«	NULL
-Stat6	NULL
(	NULL
523-659	NULL
)	NULL
]	NULL
.	NULL

(	NULL
C	NULL
)	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
h-Stat6	NULL
and	NULL
h-Stat6A677	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
introduced	NULL
in	NULL
bandshift	NULL
assays	NULL
.	NULL

The	NULL
proximal	NULL
B-casein	NULL
promoter	NULL
Stat	NULL
binding	NULL
site	NULL
served	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

Supershift	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
(	NULL
+	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
)	NULL
Staté-specific	NULL
antiserum	NULL
[	NULL
«	NULL
-Stat6	NULL
(	NULL
633-837	NULL
)	NULL
]	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Transactivation	NULL
of	NULL
a	NULL
B-casein	NULL
promoter	NULL
(	NULL
B-casein-pro	NULL
.	NULL
)	NULL

-luciferase	NULL
(	NULL
Luc	NULL
)	NULL
construct	NULL
by	NULL
h-Stat6	NULL
and	NULL
h-Stat6A677	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
IL-4	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
relative	NULL
(	NULL
rel	NULL
.	NULL
)	NULL

luciferase	NULL
activities	NULL
were	NULL
determined	NULL
.	NULL

The	NULL
B-galactosidase	NULL
gene	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
to	NULL
monitor	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
were	NULL
normalized	NULL
against	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

Four	NULL
independent	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

promoter-luciferase	NULL
reporter	NULL
construct	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

A	NULL
B-galactosidase	NULL
gene	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
,	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
served	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
transfection	NULL
efficiency	NULL
.	NULL

We	NULL
expressed	NULL
the	NULL
relative	NULL
luciferase	NULL
activity	NULL
as	NULL
the	NULL
luciferase-to-galactosidase	NULL
activity	NULL
ratio	NULL
.	NULL

We	NULL
also	NULL
derived	NULL
a	NULL
carboxyl-terminal	NULL
deletion	NULL
mutant	NULL
of	NULL
h-Stat6	NULL
to	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
this	NULL
region	NULL
in	NULL
transactivation	NULL
.	NULL

A	NULL
stop	NULL
codon	NULL
was	NULL
introduced	NULL
at	NULL
amino	NULL
acid	NULL
position	NULL
677	NULL
(	NULL
h-Stat6A677	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Upon	NULL
transfection	NULL
into	NULL
COS7	NULL
cells	NULL
and	NULL
IL-4	NULL
treatment	NULL
,	NULL
h-Stat6A677	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
specific	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
were	NULL
observed	NULL
;	NULL
h-Stat6A677	NULL
can	NULL
be	NULL
only	NULL
weakly	NULL
supershifted	NULL
.	NULL

It	NULL
lacks	NULL
the	NULL
amino	NULL
acids	NULL
,	NULL
678	NULL
to	NULL
847	NULL
,	NULL
against	NULL
which	NULL
the	NULL
antiserum	NULL
was	NULL
made	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Both	NULL
h-Stat6	NULL
and	NULL
h-Stat6A677	NULL
were	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
proximal	NULL
and	NULL
distal	NULL
B-casein	NULL
promoter	NULL
Stat	NULL
binding	NULL
sites	NULL
as	NULL
well	NULL
as	NULL
the	NULL
Stat6	NULL
binding	NULL
site	NULL
identified	NULL
in	NULL
the	NULL
immunoglobulin	NULL
g	NULL
promoter	NULL
.	NULL

The	NULL
B-casein	NULL
promoter	NULL
element	NULL
and	NULL
the	NULL
immunoglobulin	NULL
¢	NULL
site	NULL
have	NULL
a	NULL
spacing	NULL
of	NULL
4	NULL
bp	NULL
that	NULL
separates	NULL
the	NULL
palindromic	NULL
sequence	NULL
5'-TTCN	NULL
,	NULL
GAA-3	NULL
'	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
wild-type	NULL
h-Stat6	NULL
molecule	NULL
,	NULL
h-Stat6A677	NULL
was	NULL
not	NULL
able	NULL
to	NULL
support	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter-luciferase	NULL
reporter	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Sta26	NULL
cooperates	NULL
with	NULL
the	NULL
GR	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
StatS5	NULL
and	NULL
the	NULL
GR	NULL
functionally	NULL
interact	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
.	NULL

Since	NULL
the	NULL
extent	NULL
of	NULL
induction	NULL
is	NULL
dependent	NULL
upon	NULL
this	NULL
interaction	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
such	NULL
cooperation	NULL
could	NULL
also	NULL
be	NULL
observed	NULL
between	NULL
Stat6	NULL
and	NULL
the	NULL
GR	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
h-Stat6	NULL
,	NULL
the	NULL
GR	NULL
,	NULL
and	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter-luciferase	NULL
reporter	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter-luciferase	NULL
gene	NULL
was	NULL
observed	NULL
upon	NULL
IL-4	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
four	NULL
times	NULL
higher	NULL
upon	NULL
dexamethasone	NULL
and	NULL
IL-4	NULL
induction	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
GR	NULL
alone	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
introduction	NULL
of	NULL
the	NULL
h-IL-4R	NULL
a	NULL
chain	NULL
,	NULL
the	NULL
common	NULL
y	NULL
,	NULL
,	NULL
chain	NULL
,	NULL
or	NULL
both	NULL
chains	NULL
into	NULL
COS7	NULL
cells	NULL
did	NULL
not	NULL
change	NULL
the	NULL
inducibility	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

We	NULL
recently	NULL
detected	NULL
that	NULL
the	NULL
functional	NULL
IL-4-IL-13	NULL
receptor	NULL
system	NULL
is	NULL
endogenously	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
(	NULL
43a	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
(	NULL
s-casein-pro	NULL
.	NULL
)	NULL

-344	NULL
~144	NULL
0+	NULL
97	NULL
~89	NULL
-1	NULL
G	NULL
O	NULL
5	NULL
O	NULL
71	NULL
~	NULL
40—	NULL
b-2	NULL
T	NULL
o	NULL
#	NULL
©	NULL
5	NULL
3	NULL
O	NULL
7	NULL
o	NULL
~	NULL
2	NULL
p	NULL
1-9	NULL
_	NULL
0	NULL
3	NULL
2	NULL
O	NULL
5	NULL
8	NULL
<	NULL
3	NULL
&	NULL
as	NULL
7	NULL
O7	NULL
P	NULL
h-IL-4	NULL
|-	NULL
|	NULL
+	NULL
|-	NULL
[	NULL
+	NULL
]	NULL
-	NULL
|	NULL
+	NULL
Dex	NULL
|	NULL
-	NULL
|	NULL
-	NULL
|-	NULL
|	NULL
+	NULL
|	NULL
-	NULL
|	NULL
+	NULL
h-Staté	NULL
|	NULL
_+	NULL
|	NULL
+	NULL
|	NULL
+	NULL
|	NULL
+	NULL
|	NULL
-	NULL
|	NULL
GR	NULL
|	NULL
+	NULL
|	NULL
+	NULL
[	NULL
+	NULL
[	NULL
+	NULL
[	NULL
+	NULL
|	NULL
+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Dexamethasone	NULL
(	NULL
Dex	NULL
)	NULL
induction	NULL
of	NULL
the	NULL
GR	NULL
and	NULL
IL-4	NULL
induction	NULL
of	NULL
Stat6	NULL
result	NULL
in	NULL
cooperation	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
B-casein	NULL
gene	NULL
transcription	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
h-Stat6	NULL
,	NULL
the	NULL
GR	NULL
,	NULL
a	NULL
B-casein	NULL
promoter	NULL
(	NULL
B-casein-pro	NULL
.	NULL
)	NULL

-luciferase	NULL
(	NULL
Luc	NULL
)	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
(	NULL
+	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
)	NULL
IL-4	NULL
or	NULL
dexamethasone	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
relative	NULL
(	NULL
rel	NULL
.	NULL
)	NULL

luciferase	NULL
activities	NULL
were	NULL
determined	NULL
.	NULL

The	NULL
B-galactosidase	NULL
gene	NULL
was	NULL
included	NULL
to	NULL
monitor	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
were	NULL
normalized	NULL
against	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

Three	NULL
independent	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

The	NULL
carboxyl	NULL
terminal	NULL
domain	NULL
of	NULL
Stat6	NULL
contains	NULL
a	NULL
strong	NULL
,	NULL
autonomous	NULL
transactivation	NULL
domain	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
170	NULL
amino	NULL
acids	NULL
of	NULL
Stat6	NULL
resulted	NULL
in	NULL
the	NULL
loss	NULL
of	NULL
transcriptional	NULL
induction	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
this	NULL
region	NULL
corresponds	NULL
to	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
the	NULL
molecule	NULL
,	NULL
we	NULL
constructed	NULL
chimeric	NULL
proteins	NULL
consisting	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
yeast	NULL
transcription	NULL
factor	NULL
GAL4	NULL
(	NULL
56	NULL
)	NULL
and	NULL
segments	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
h-Stat6	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
acidic	NULL
transactivation	NULL
domain	NULL
of	NULL
VP16	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
55	NULL
)	NULL
.	NULL

The	NULL
transactivation	NULL
domain	NULL
of	NULL
StatSa	NULL
was	NULL
used	NULL
for	NULL
comparison	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
chimeric	NULL
genes	NULL
were	NULL
cloned	NULL
into	NULL
expression	NULL
vectors	NULL
and	NULL
transfected	NULL
into	NULL
COS7	NULL
cells	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
GAL4-Stat6	NULL
fusion	NULL
proteins	NULL
was	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
a	NULL
GAL4-specific	NULL
antibody	NULL
.	NULL

Fusion	NULL
proteins	NULL
of	NULL
the	NULL
expected	NULL
sizes	NULL
were	NULL
detected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
transfected	NULL
cells	NULL
and	NULL
analyzed	NULL
in	NULL
bandshift	NULL
assays	NULL
.	NULL

The	NULL
specific	NULL
DNA	NULL
sequence	NULL
recognized	NULL
by	NULL
GALA	NULL
was	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

All	NULL
fusion	NULL
proteins	NULL
were	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
palindromic	NULL
GALA	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
24	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
binding	NULL
was	NULL
examined	NULL
in	NULL
supershift	NULL
assays	NULL
with	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
even-numbered	NULL
lanes	NULL
)	NULL
.	NULL

The	NULL
transactivation	NULL
potential	NULL
of	NULL
GAL4-Stat6	NULL
fusion	NULL
proteins	NULL
were	NULL
tested	NULL
.	NULL

A	NULL
luciferase	NULL
reporter	NULL
construct	NULL
containing	NULL
three	NULL
GALA	NULL
binding	NULL
sites	NULL
in	NULL
its	NULL
promoter	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
GALA-Stat6	NULL
fusion	NULL
proteins	NULL
and	NULL
a	NULL
B-galactosidase	NULL
gene	NULL
into	NULL
COS7	NULL
cells	NULL
.	NULL

Luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
were	NULL
measured	NULL
,	NULL
and	NULL
the	NULL
ratios	NULL
of	NULL
the	NULL
two	NULL
activities	NULL
were	NULL
plotted	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

GALA4-642-847	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
TRANSACTIVATION	NULL
DOMAINS	NULL
OF	NULL
Stat	NULL
FACTORS	NULL
-	NULL
3667	NULL
GALA-677-847	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
showed	NULL
15-fold-higher	NULL
activities	NULL
than	NULL
that	NULL
of	NULL
the	NULL
GALA	NULL
control	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
;	NULL
the	NULL
activities	NULL
of	NULL
GALA4-705-847	NULL
and	NULL
GALA-754-847	NULL
were	NULL
about	NULL
7-fold	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
GALA	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
transactivation	NULL
was	NULL
detected	NULL
when	NULL
GALA4-792-847	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
GALA-677-704	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
or	NULL
GALA4-754-791	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
was	NULL
employed	NULL
.	NULL

GAL4-677-791	NULL
retained	NULL
considerable	NULL
transactivation	NULL
potential	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Very	NULL
strong	NULL
transactivation	NULL
(	NULL
275-fold	NULL
)	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
was	NULL
fused	NULL
to	NULL
VP16	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

Only	NULL
weak	NULL
transactivation	NULL
(	NULL
threefold	NULL
)	NULL
was	NULL
observed	NULL
for	NULL
the	NULL
GAL4-Stat5a-722-794	NULL
fusion	NULL
protein	NULL
.	NULL

The	NULL
transactivation	NULL
domain	NULL
of	NULL
Stat6	NULL
functions	NULL
efficiently	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

IL-4-dependent	NULL
gene	NULL
regulation	NULL
mediated	NULL
by	NULL
Stat6	NULL
was	NULL
originally	NULL
studied	NULL
with	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
inducible	NULL
gene	NULL
promoters	NULL
were	NULL
characterized	NULL
.	NULL

Stat	NULL
factor	NULL
activation	NULL
in	NULL
lymphocytes	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
Stat6	NULL
;	NULL
Stat5	NULL
can	NULL
be	NULL
activated	NULL
in	NULL
these	NULL
cells	NULL
by	NULL
cytokines	NULL
like	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
or	NULL
prolactin	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
a	NULL
Stat	NULL
factor	NULL
is	NULL
cell	NULL
type	NULL
specific	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
Stat5	NULL
and	NULL
Stat6	NULL
in	NULL
Ba/F3	NULL
cells	NULL
.	NULL

Ba/F3	NULL
cells	NULL
are	NULL
pre-B	NULL
cells	NULL
which	NULL
depend	NULL
on	NULL
IL-3	NULL
for	NULL
growth	NULL
.	NULL

For	NULL
our	NULL
experiments	NULL
,	NULL
we	NULL
used	NULL
a	NULL
Ba/F3	NULL
cell	NULL
line	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
mouse	NULL
prolactin	NULL
receptor	NULL
(	NULL
Ba/F3-PR	NULL
)	NULL
(	NULL
12	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
can	NULL
grow	NULL
in	NULL
prolactin	NULL
or	NULL
IL-3	NULL
.	NULL

Both	NULL
cytokines	NULL
activate	NULL
Stat5	NULL
but	NULL
not	NULL
Stat6	NULL
,	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
transactivation	NULL
potentials	NULL
of	NULL
GAL4	NULL
fusion	NULL
constructs	NULL
were	NULL
tested	NULL
by	NULL
cotransfection	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
construct	NULL
containing	NULL
three	NULL
GALA	NULL
binding	NULL
sites	NULL
in	NULL
its	NULL
promoter	NULL
into	NULL
Ba/	NULL
F3-PR	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

GAL4-642-847	NULL
,	NULL
GALA4-677-847	NULL
,	NULL
and	NULL
GALA-705-847	NULL
caused	NULL
a	NULL
>	NULL
100-fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
)	NULL
,	NULL
and	NULL
GALA-754-847	NULL
and	NULL
GAL4-677-791	NULL
caused	NULL
about	NULL
70-fold	NULL
induction	NULL
(	NULL
lanes	NULL
13	NULL
,	NULL
14	NULL
,	NULL
17	NULL
,	NULL
and	NULL
18	NULL
)	NULL
.	NULL

Very	NULL
weak	NULL
induction	NULL
was	NULL
observed	NULL
when	NULL
GALA-792-847	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
,	NULL
GALA-677-704	NULL
(	NULL
lanes	NULL
19	NULL
and	NULL
20	NULL
)	NULL
,	NULL
and	NULL
GALA-754-791	NULL
(	NULL
lanes	NULL
21	NULL
and	NULL
22	NULL
)	NULL
were	NULL
used	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
ones	NULL
observed	NULL
for	NULL
transfected	NULL
COS7	NULL
cells	NULL
.	NULL

When	NULL
we	NULL
compared	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
Stata	NULL
and	NULL
VP16	NULL
with	NULL
that	NULL
of	NULL
Stat6	NULL
,	NULL
cell-type-specific	NULL
effects	NULL
were	NULL
found	NULL
.	NULL

GAL4-Stat5a-722-794	NULL
showed	NULL
only	NULL
threefold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
and	NULL
GALA-VP16	NULL
showed	NULL
60-	NULL
to	NULL
100-fold	NULL
induction	NULL
(	NULL
lanes	NULL
23	NULL
and	NULL
24	NULL
)	NULL
.	NULL

Transactivation	NULL
by	NULL
GALA-VP16	NULL
is	NULL
slightly	NULL
lower	NULL
in	NULL
Ba/F3-PR	NULL
cells	NULL
than	NULL
is	NULL
transactivation	NULL
by	NULL
the	NULL
optimal	NULL
Stat6	NULL
constructs	NULL
(	NULL
GALA-642-847	NULL
,	NULL
GALA-677-847	NULL
,	NULL
and	NULL
GALA-705-847	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
data	NULL
obtained	NULL
with	NULL
COS7	NULL
cells	NULL
,	NULL
where	NULL
GALA-VP16	NULL
caused	NULL
10-fold-higher	NULL
transactivation	NULL
than	NULL
did	NULL
the	NULL
optimal	NULL
Stat6	NULL
constructs	NULL
.	NULL

No	NULL
cell-type-specific	NULL
effects	NULL
were	NULL
observed	NULL
for	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
StatS5	NULL
.	NULL

The	NULL
treatment	NULL
of	NULL
transfected	NULL
cells	NULL
with	NULL
prolactin	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
luciferase	NULL
activities	NULL
We	NULL
conclude	NULL
that	NULL
Stat6	NULL
contains	NULL
a	NULL
transactivation	NULL
domain	NULL
which	NULL
functions	NULL
with	NULL
different	NULL
efficiencies	NULL
in	NULL
COS7	NULL
and	NULL
Ba/F3	NULL
cells	NULL
.	NULL

StatSa	NULL
contains	NULL
a	NULL
transactivation	NULL
domain	NULL
which	NULL
functions	NULL
only	NULL
weakly	NULL
in	NULL
COS7	NULL
and	NULL
Ba/F3-PR	NULL
cells	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
transactivation	NULL
domains	NULL
of	NULL
StatSa	NULL
and	NULL
Stat6	NULL
are	NULL
not	NULL
influenced	NULL
by	NULL
growth-promoting	NULL
conditions	NULL
in	NULL
Ba/F3-PR	NULL
cells	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
action	NULL
of	NULL
prolactin	NULL
.	NULL

The	NULL
transactivation	NULL
domain	NULL
of	NULL
h-Stat6	NULL
independently	NULL
of	NULL
its	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
is	NULL
IL-4	NULL
inducible	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
function	NULL
of	NULL
Stat6	NULL
is	NULL
activated	NULL
by	NULL
IL-4	NULL
through	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
641	NULL
(	NULL
43	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
whether	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
Stat6	NULL
is	NULL
constitutively	NULL
active	NULL
or	NULL
this	NULL
function	NULL
is	NULL
also	NULL
influenced	NULL
by	NULL
IL-4R	NULL
activation	NULL
in	NULL
Ba/F3	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
used	NULL
a	NULL
Ba/F3	NULL
cell	NULL
line	NULL
stably	NULL
expressing	NULL
the	NULL
human	NULL
IL-4R	NULL
a	NULL
and	NULL
y	NULL
,	NULL
,	NULL
chains	NULL
(	NULL
Ba/F3-IL4R	NULL
)	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Mouse	NULL
IL-4	NULL
,	NULL
via	NULL
the	NULL
endogenous	NULL
IL-4R	NULL
,	NULL
and	NULL
human	NULL
IL-4	NULL
,	NULL
via	NULL
the	NULL
transfected	NULL
human	NULL
receptor	NULL
,	NULL
caused	NULL
the	NULL
induction	NULL
of	NULL
spe-	NULL
3668	NULL
MORIGGL	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

h-	NULL
Stat	NULL
6	NULL
GALA	NULL
-A64	NULL
2-847	NULL
GAL4-A677-847	NULL
GaAL4-A705-847	NULL
aa	NULL
1	NULL
147	NULL
,	NULL
GALA-A754-847	NULL
aa	NULL
1	NULL
147	NULL
,	NULL
GALA	NULL
-A792-847	NULL
147	NULL
GAL4-A677-791	NULL
GALA-A677-704	NULL
MGF-	NULL
Stat	NULL
5	NULL
a	NULL
aa	NULL
L	NULL
147	NULL
GAL4A-	NULL
St	NULL
at	NULL
5a	NULL
A7	NULL
22-7	NULL
94	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Expression	NULL
,	NULL
DNA	NULL
binding	NULL
,	NULL
and	NULL
transcriptional	NULL
induction	NULL
of	NULL
GAL4-Stat6	NULL
transactivation	NULL
domain	NULL
fusion	NULL
proteins	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Structures	NULL
of	NULL
GAL4-Stat6	NULL
fusion	NULL
proteins	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
domain	NULL
of	NULL
yeast	NULL
GALA	NULL
(	NULL
amino	NULL
acids	NULL
[	NULL
aa	NULL
]	NULL
1	NULL
to	NULL
147	NULL
)	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
,	NULL
and	NULL
the	NULL
regions	NULL
of	NULL
h-Stat6	NULL
or	NULL
MGF-StatSa	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

The	NULL
names	NULL
of	NULL
constructs	NULL
and	NULL
the	NULL
amino	NULL
acid	NULL
positions	NULL
of	NULL
fused	NULL
regions	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
phosphorylation	NULL
site	NULL
(	NULL
Y	NULL
)	NULL
is	NULL
also	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
GAL4	NULL
and	NULL
GALA4-Stat6	NULL
and	NULL
GAL4-Stat5a	NULL
fusion	NULL
proteins	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
fusion	NULL
constructs	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
introduced	NULL
in	NULL
bandshift	NULL
assays	NULL
.	NULL

The	NULL
GALA4-specific	NULL
binding	NULL
site	NULL
served	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

Supershift	NULL
experiments	NULL
with	NULL
(	NULL
+	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
)	NULL
a	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GALA	NULL
(	NULL
«	NULL
-GAL4	NULL
)	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Transactivation	NULL
by	NULL
GALA	NULL
,	NULL
GAL4-Stat6	NULL
,	NULL
GALA-VP16	NULL
and	NULL
GALA-StatSa	NULL
.	NULL

Fusion	NULL
genes	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
GALA-reporter	NULL
construct	NULL
[	NULL
(	NULL
Gal4-RE	NULL
)	NULL
;	NULL
]	NULL
into	NULL
COS7	NULL
cells	NULL
.	NULL

The	NULL
B-galactosidase	NULL
gene	NULL
was	NULL
included	NULL
to	NULL
monitor	NULL
transfection	NULL
efficiency	NULL
.	NULL

Relative	NULL
(	NULL
rel	NULL
.	NULL
)	NULL

luciferase	NULL
activities	NULL
were	NULL
determined	NULL
and	NULL
normalized	NULL
with	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

Each	NULL
luciferase	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
fold	NULL
activation	NULL
with	NULL
respect	NULL
to	NULL
that	NULL
of	NULL
the	NULL
GALA-luciferase	NULL
(	NULL
Luc	NULL
)	NULL
reporter	NULL
construct	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cotransfected	NULL
factors	NULL
.	NULL

Five	NULL
independent	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

cific	NULL
Stat6-DNA	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
identities	NULL
of	NULL
IL-4-induced	NULL
complexes	NULL
were	NULL
verified	NULL
by	NULL
supershift	NULL
experiments	NULL
with	NULL
Staté-specific	NULL
chicken	NULL
antiserum	NULL
,	NULL
directed	NULL
against	NULL
Stat6	NULL
(	NULL
633-837	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
human	NULL
IL-4	NULL
induction	NULL
and	NULL
activation	NULL
of	NULL
Stat6	NULL
in	NULL
Ba/F3-IL4R	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
minimal	NULL
promoter	NULL
element	NULL
with	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
Stat6	NULL
response	NULL
element	NULL
from	NULL
the	NULL
immunoglobulin	NULL
g	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
TK	NULL
promoter	NULL
and	NULL
a	NULL
luciferase	NULL
gene	NULL
[	NULL
N4	NULL
(	NULL
Stat-RE	NULL
)	NULL
3-tk-luc	NULL
]	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
dyad	NULL
Stat6	NULL
half	NULL
sites	NULL
are	NULL
separated	NULL
by	NULL
4	NULL
nucleotides	NULL
.	NULL

In	NULL
troduction	NULL
of	NULL
the	NULL
N4	NULL
(	NULL
Stat-RE	NULL
)	NULL
3-tk-lue	NULL
reporter	NULL
construct	NULL
in	NULL
Ba/F3-IL4R	NULL
cells	NULL
by	NULL
electroporation	NULL
led	NULL
to	NULL
fivefold	NULL
induction	NULL
upon	NULL
IL-4	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

This	NULL
induction	NULL
was	NULL
further	NULL
enhanced	NULL
when	NULL
h-Stat6	NULL
was	NULL
cotransfected	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
Stat6	NULL
by	NULL
IL-4	NULL
not	NULL
only	NULL
is	NULL
dependent	NULL
on	NULL
regulation	NULL
of	NULL
the	NULL
Stat6	NULL
DNA	NULL
binding	NULL
activity	NULL
but	NULL
also	NULL
is	NULL
mediated	NULL
by	NULL
control	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
.	NULL

GALA	NULL
,	NULL
GALA4-Stat6-677-791	NULL
,	NULL
GALA-VP16	NULL
,	NULL
and	NULL
the	NULL
(	NULL
GALA4-RE	NULL
)	NULL
3-tk-lue	NULL
reporter	NULL
construct	NULL
were	NULL
tran	NULL
TRANSACTIVATION	NULL
DOMAINS	NULL
OF	NULL
Stat	NULL
FACTORS	NULL
-	NULL
3669	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
$	NULL
&	NULL
B	NULL
d	NULL
b	NULL
b	NULL
5	NULL
S	NULL
5	NULL
¢	NULL
tee	NULL
§	NULL
P	NULL
O	NULL
@	NULL
O	NULL
®	NULL
»	NULL
®	NULL
f	NULL
:	NULL
ll	NULL
&	NULL
-	NULL
iD	NULL
£	NULL
a	NULL
No	NULL
wo	NULL
y	NULL
a	NULL
Mo-	NULL
_s	NULL
&	NULL
e	NULL
2	NULL
§	NULL
5	NULL
$	NULL
$	NULL
$	NULL
5	NULL
§	NULL
$	NULL
_	NULL
$	NULL
$	NULL
,	NULL
£009	NULL
oy	NULL
oy	NULL
oy	NULL
yo	NULL
yoy	NULL
fof	NULL
f	NULL
f®	NULL
tus	NULL
pcd	NULL
``	NULL
ee	NULL
ww	NULL
``	NULL
ew	NULL
~s	NULL
``	NULL
awe	NULL
PC	NULL
bud	NULL
ww	NULL
~s	NULL
0	NULL
C	NULL
C	NULL
&	NULL
CG	NULL
C	NULL
&	NULL
C	NULL
&	NULL
C	NULL
&	NULL
C	NULL
CG	NULL
C	NULL
&	NULL
ft	NULL
&	NULL
CV	NULL
3	NULL
0	NULL
0	NULL
0	NULL
0G	NULL
O0	NULL
OG	NULL
0	NULL
OG	NULL
0	NULL
O0	NULL
G0	NULL
o-GAL4	NULL
[	NULL
-	NULL
+	NULL
]	NULL
+	NULL
]	NULL
free	NULL
probe	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
1415	NULL
16	NULL
1718	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
C	NULL
(	NULL
Gal4-RE	NULL
)	NULL
3	NULL
{	NULL
1	NULL
[	NULL
2	NULL
}	NULL
3	NULL
}	NULL
|_	NULL
TK	NULL
éLuc§	NULL
C	NULL
rel	NULL
.	NULL

luciferase	NULL
activity	NULL
(	NULL
arbitary	NULL
units	NULL
)	NULL
Gald-	NULL
Gald-	NULL
Gald-	NULL
Gald-	NULL
Gald-	NULL
Gald-	NULL
tat	NULL
TOS-R47	NULL
TRENT	NULL
792-847	NULL
677-791	NULL
677.704	NULL
754.791	NULL
VP	NULL
.	NULL

16	NULL
722.794	NULL
1	NULL
20	NULL
3	NULL
4	NULL
5006	NULL
70	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
FIG	NULL
.	NULL

4-Continued	NULL
.	NULL

3670	NULL
MORIGGL	NULL
ET	NULL
AL	NULL
.	NULL

150	NULL
7-7	NULL
mh	NULL
0	NULL
h	NULL
rel	NULL
.	NULL

luciferase	NULL
activity	NULL
(	NULL
arbitary	NULL
units	NULL
)	NULL
4	NULL
9	NULL
1x	NULL
1x	NULL
z	NULL
3x	NULL
RE	NULL
Gald	NULL
Gald	NULL
(	NULL
GalId4-RE	NULL
)	NULL
3	NULL
677-847	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Gald-	NULL
``	NULL
677-791	NULL
Gald-705-847	NULL
Gald-754-847	NULL
Gald-792-847	NULL
Gald-754-791	NULL
Gald-VP-16	NULL
-	NULL
|+Prl	NULL
=	NULL
--	NULL
I+Prl	NULL
-	NULL
|+Prl	NULL
--	NULL
|+Prl	NULL
-	NULL
I+Prl	NULL
-	NULL
|+Prl	NULL
--	NULL
I+Prl	NULL
-	NULL
|+Prl	NULL
-	NULL
|+Prl	NULL
-	NULL
|+Prl	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
09	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Transactivation	NULL
of	NULL
a	NULL
GAL4-luciferase	NULL
construct	NULL
by	NULL
GALA4-Stat6	NULL
fusion	NULL
proteins	NULL
in	NULL
Ba/F3-PR	NULL
lymphocytes	NULL
is	NULL
not	NULL
regulated	NULL
by	NULL
prolactin	NULL
.	NULL

The	NULL
GALA-Stat6	NULL
fusion	NULL
genes	NULL
indicated	NULL
were	NULL
introduced	NULL
together	NULL
with	NULL
a	NULL
GAL4-luciferase	NULL
(	NULL
Luc	NULL
)	NULL
reporter	NULL
gene	NULL
by	NULL
electroporation	NULL
into	NULL
Ba/F3-PR	NULL
cells	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
(	NULL
+	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
)	NULL
prolactin	NULL
(	NULL
Pri	NULL
)	NULL
for	NULL
20	NULL
h.	NULL
Relative	NULL
(	NULL
rel	NULL
.	NULL
)	NULL

luciferase	NULL
activities	NULL
were	NULL
determined	NULL
24	NULL
h	NULL
after	NULL
electroporation	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
of	NULL
the	NULL
GAL4	NULL
reporter	NULL
construct	NULL
[	NULL
(	NULL
Gal4-RE	NULL
)	NULL
;	NULL
]	NULL
was	NULL
considered	NULL
1	NULL
.	NULL

Four	NULL
independent	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

siently	NULL
transfected	NULL
into	NULL
Ba/F3-IL4R	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
kept	NULL
in	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
IL-4	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
luciferase	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
were	NULL
determined	NULL
.	NULL

The	NULL
reporter	NULL
construct	NULL
and	NULL
GAL4	NULL
showed	NULL
no	NULL
significant	NULL
luciferase	NULL
activity	NULL
upon	NULL
human	NULL
IL-4	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Strong	NULL
luciferase	NULL
activity	NULL
was	NULL
obtained	NULL
for	NULL
GALA-Stat6-677-791	NULL
,	NULL
and	NULL
it	NULL
was	NULL
significantly	NULL
upregulated	NULL
upon	NULL
IL-4	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GALA-VP16	NULL
showed	NULL
no	NULL
such	NULL
upregulation	NULL
upon	NULL
IL-4	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
were	NULL
repeated	NULL
four	NULL
times	NULL
with	NULL
consistent	NULL
results	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
IL-4-dependent	NULL
regulation	NULL
of	NULL
the	NULL
Stat6	NULL
transactivation	NULL
domain	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
the	NULL
constructs	NULL
GALA-642-847	NULL
,	NULL
GALA4-677-847	NULL
,	NULL
and	NULL
GALA-705-847	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

When	NULL
the	NULL
activities	NULL
in	NULL
extracts	NULL
from	NULL
IL-4-treated	NULL
and	NULL
untreated	NULL
cells	NULL
were	NULL
compared	NULL
,	NULL
we	NULL
found	NULL
that	NULL
luciferase	NULL
activity	NULL
was	NULL
enhanced	NULL
upon	NULL
cytokine	NULL
treatment	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
constructs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Provision	NULL
with	NULL
the	NULL
Stat6	NULL
transactivation	NULL
domain	NULL
enhances	NULL
Stat5	NULL
induction	NULL
of	NULL
the	NULL
B-casein	NULL
,	NULL
CIS	NULL
,	NULL
and	NULL
OSM	NULL
gene	NULL
promot-ers	NULL
.	NULL

We	NULL
recently	NULL
mapped	NULL
the	NULL
Stat5	NULL
transactivation	NULL
domain	NULL
,	NULL
and	NULL
a	NULL
region	NULL
between	NULL
amino	NULL
acid	NULL
positions	NULL
750	NULL
and	NULL
794	NULL
was	NULL
found	NULL
to	NULL
be	NULL
absolutely	NULL
required	NULL
for	NULL
gene	NULL
transcription	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
experiments	NULL
described	NULL
above	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
indicate	NULL
that	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
StatSa	NULL
is	NULL
weaker	NULL
than	NULL
that	NULL
of	NULL
Stat6	NULL
when	NULL
linked	NULL
to	NULL
a	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
strength	NULL
of	NULL
the	NULL
Stat5	NULL
and	NULL
Stat6	NULL
transactivation	NULL
domains	NULL
within	NULL
the	NULL
context	NULL
of	NULL
a	NULL
Stat	NULL
molecule	NULL
,	NULL
we	NULL
exchanged	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
Stat5	NULL
with	NULL
different	NULL
parts	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
Stat6	NULL
.	NULL

The	NULL
variant	NULL
of	NULL
StatSa	NULL
lacking	NULL
the	NULL
carboxyl-terminal	NULL
44	NULL
amino	NULL
acids	NULL
(	NULL
StatSaA750	NULL
)	NULL
served	NULL
as	NULL
the	NULL
starting	NULL
point	NULL
.	NULL

This	NULL
molecule	NULL
is	NULL
not	NULL
able	NULL
to	NULL
support	NULL
transactivation	NULL
by	NULL
itself	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Amino	NULL
acids	NULL
677	NULL
to	NULL
847	NULL
,	NULL
705	NULL
to	NULL
847	NULL
,	NULL
754	NULL
to	NULL
847	NULL
,	NULL
792	NULL
to	NULL
847	NULL
,	NULL
and	NULL
677	NULL
to	NULL
791	NULL
of	NULL
Stat6	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
carboxyl-terminal	NULL
end	NULL
of	NULL
Stat5aA750	NULL
.	NULL

A	NULL
fusion	NULL
with	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
VP16	NULL
(	NULL
amino	NULL
acids	NULL
411	NULL
to	NULL
489	NULL
)	NULL
served	NULL
as	NULL
a	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
prolactin	NULL
receptor	NULL
,	NULL
StatS5-Stat6	NULL
fusion	NULL
constructs	NULL
,	NULL
and	NULL
a	NULL
B-casein	NULL
gene	NULL
promoter-luciferase	NULL
construct	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Stat5-Stat6	NULL
proteins	NULL
was	NULL
visualized	NULL
by	NULL
Western	NULL
blotting	NULL
analysis	NULL
with	NULL
a	NULL
specific	NULL
chicken	NULL
antiserum	NULL
directed	NULL
against	NULL
the	NULL
carboxyl-terminal	NULL
domain	NULL
of	NULL
Stat6	NULL
[	NULL
Stat6	NULL
(	NULL
633-837	NULL
)	NULL
]	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
;	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat5-Stat6	NULL
proteins	NULL
upon	NULL
prolactin	NULL
treatment	NULL
of	NULL
transfected	NULL
cells	NULL
was	NULL
shown	NULL
by	NULL
Western	NULL
blotting	NULL
analysis	NULL
with	NULL
a	NULL
phosphotyrosine-specific	NULL
antibody	NULL
(	NULL
PY20	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
;	NULL
specific	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
bandshift	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Supershift	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
Staté6-specific	NULL
polyclonal	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
and	NULL
15	NULL
)	NULL
.	NULL

All	NULL
five	NULL
Stat5-Stat6	NULL
fusion	NULL
proteins	NULL
can	NULL
be	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
acquire	NULL
specific	NULL
DNA	NULL
binding	NULL
activity	NULL
upon	NULL
prolactin	NULL
treatment	NULL
of	NULL
transfected	NULL
cells	NULL
.	NULL

The	NULL
transactivation	NULL
potentials	NULL
of	NULL
StatSa	NULL
,	NULL
StatSaA750	NULL
,	NULL
and	NULL
Stat5-Stat6	NULL
fusion	NULL
proteins	NULL
were	NULL
measured	NULL
with	NULL
a	NULL
B-casein	NULL
gene	NULL
promoter-luciferase	NULL
construct	NULL
.	NULL

Wild-type	NULL
StatSa	NULL
mediated	NULL
a	NULL
15-fold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
upon	NULL
prolactin	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

StatSaA750	NULL
was	NULL
unable	NULL
to	NULL
support	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

StatSaA750-Stat6-677-847	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
StatSaA750-Stat6-705-847	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
StatSaA750-Stat6-754-847	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
,	NULL
and	NULL
StatSaA750-Stat6-677-791	NULL
(	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
caused	NULL
very	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
TRANSACTIVATION	NULL
DOMAINS	NULL
OF	NULL
Stat	NULL
FACTORS	NULL
-	NULL
3671	NULL
A	NULL
B	NULL
N4	NULL
(	NULL
Stat6-RE	NULL
)	NULL
3	NULL
Coel	NULL
freq	NULL
1000-supershift	NULL
-	NULL
»	NULL
soo-3	NULL
‘	NULL
s0oo-Stat6-complex-p	NULL
>	NULL
&	NULL
.	NULL

5	NULL
2	NULL
6	NULL
c	NULL
$	NULL
3	NULL
400-s	NULL
2	NULL
;	NULL
3	NULL
§	NULL
|	NULL
TF	NULL
``	NULL
C	NULL
2	NULL
2004	NULL
h-IL-	NULL
4	NULL
|	NULL
-	NULL
|	NULL
-	NULL
|	NULL
4+	NULL
|	NULL
4+-|	NULL
-	NULL
3	NULL
S	NULL
m-IL-4	NULL
]	NULL
-|	NULL
4+	NULL
]	NULL
-	NULL
|	NULL
-	NULL
|+	NULL
®	NULL
0	NULL
|F	NULL
h-Stat6	NULL
|	NULL
-	NULL
|	NULL
=-	NULL
|	NULL
+	NULL
«	NULL
-Stat6	NULL
+/+	NULL
h-4	NULL
L-4	NULL
[	NULL
1	NULL
2345	NULL
123	NULL
4	NULL
C	NULL
400	NULL
300	NULL
>	NULL
a	NULL
t	NULL
2	NULL
m	NULL
15	NULL
2	NULL
200	NULL
6	NULL
c	NULL
o	NULL
3	NULL
$	NULL
>	NULL
100	NULL
fy	NULL
$	NULL
5	NULL
G	NULL
2	NULL
E	NULL
o	NULL
1X	NULL
1X	NULL
Gald-	NULL
Gald	NULL
_s	NULL
gn	NULL
BE	NULL
pot	NULL
677-701	NULL
_|	NULL
vrs	NULL
©	NULL
44	NULL
-	NULL
||1	NULL
,	NULL
_4	NULL
-	NULL
[	NULL
m4	NULL
W	NULL
I	NULL
``	NULL
,4	NULL
--	NULL
IlL-4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Transactivation	NULL
of	NULL
a	NULL
GALA4-luciferase	NULL
construct	NULL
by	NULL
GAL4-Stat6	NULL
fusion	NULL
proteins	NULL
in	NULL
Ba/F3-IL4R	NULL
lymphocytes	NULL
is	NULL
regulated	NULL
by	NULL
IL-4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
murine	NULL
Stat6é	NULL
(	NULL
m-Stat6	NULL
)	NULL
and	NULL
h-Stat6	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
introduced	NULL
into	NULL
bandshift	NULL
assays	NULL
.	NULL

The	NULL
B-casein	NULL
promoter	NULL
Stat	NULL
binding	NULL
site	NULL
was	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Supershift	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
(	NULL
+	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
)	NULL
Stat6	NULL
(	NULL
633	NULL
to	NULL
837	NULL
)	NULL
-specific	NULL
antiserum	NULL
(	NULL
B-Stat6	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transcriptional	NULL
activation	NULL
of	NULL
Stat6	NULL
in	NULL
Ba/F3-ILAR	NULL
cells	NULL
.	NULL

Ba/F3-ILAR	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
Stat6	NULL
response	NULL
element	NULL
(	NULL
immunoglobulin	NULL
germ	NULL
line	NULL
heavy-chain	NULL
£	NULL
promoter	NULL
)	NULL
[	NULL
N4	NULL
(	NULL
Stat6é-RE	NULL
)	NULL
;	NULL
]	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
and	NULL
the	NULL
h-Stat6	NULL
gene	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
(	NULL
+	NULL
)	NULL
human	NULL
IL-4	NULL
for	NULL
20	NULL
h	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
or	NULL
left	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
.	NULL

Relative	NULL
(	NULL
rel	NULL
.	NULL
)	NULL

luciferase	NULL
activities	NULL
were	NULL
determined	NULL
at	NULL
24	NULL
h	NULL
after	NULL
electroporation	NULL
.	NULL

Three	NULL
independent	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Ba/F3-ILAR	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
GAL4	NULL
fusion	NULL
constructs	NULL
indicated	NULL
and	NULL
a	NULL
GALA-luciferase	NULL
reporter	NULL
construct	NULL
[	NULL
(	NULL
GALA-RE	NULL
)	NULL
;	NULL
]	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IL-4	NULL
for	NULL
20	NULL
h	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
.	NULL

Relative	NULL
(	NULL
rel	NULL
.	NULL
)	NULL

luciferase	NULL
activities	NULL
were	NULL
determined	NULL
at	NULL
24	NULL
h	NULL
after	NULL
electroporation	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
of	NULL
the	NULL
GALA-luciferase	NULL
reporter	NULL
construct	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cotransfected	NULL
factor	NULL
constructs	NULL
was	NULL
considered	NULL
1	NULL
.	NULL

Four	NULL
independent	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

strong	NULL
induction	NULL
upon	NULL
prolactin	NULL
activation	NULL
.	NULL

The	NULL
induction	NULL
was	NULL
four	NULL
to	NULL
five	NULL
times	NULL
higher	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
authentic	NULL
Stat5	NULL
molecule	NULL
.	NULL

Slightly	NULL
lower	NULL
induction	NULL
was	NULL
observed	NULL
with	NULL
StatSaA750-Stat6-792-847	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
,	NULL
but	NULL
it	NULL
still	NULL
exceeded	NULL
that	NULL
of	NULL
wild-type	NULL
Stat5	NULL
.	NULL

We	NULL
also	NULL
determined	NULL
the	NULL
potentials	NULL
of	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
Stat5	NULL
and	NULL
Stat6	NULL
by	NULL
using	NULL
a	NULL
construct	NULL
with	NULL
multimerized	NULL
Stats	NULL
binding	NULL
sites	NULL
in	NULL
its	NULL
promoter	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

The	NULL
high-affinity	NULL
proximal	NULL
Stat	NULL
site	NULL
in	NULL
the	NULL
B-casein	NULL
promoter	NULL
,	NULL
with	NULL
the	NULL
dyad	NULL
Stats	NULL
half	NULL
sites	NULL
separated	NULL
by	NULL
3	NULL
nucleotides	NULL
,	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
TK	NULL
promoter	NULL
and	NULL
a	NULL
luciferase	NULL
gene	NULL
[	NULL
N3	NULL
(	NULL
Stat-RE	NULL
)	NULL
6-tk-luc	NULL
]	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
N3	NULL
(	NULL
Stat-RE	NULL
)	NULL
6-tk-luc	NULL
reporter	NULL
construct	NULL
,	NULL
the	NULL
prolactin	NULL
receptor	NULL
,	NULL
MGF-Stat5a	NULL
,	NULL
MGF-Stat5aA750	NULL
,	NULL
and	NULL
Stat5-Stat6	NULL
fusion	NULL
proteins	NULL
were	NULL
introduced	NULL
into	NULL
COS7	NULL
cells	NULL
.	NULL

Strong	NULL
transcriptional	NULL
activation	NULL
upon	NULL
prolactin	NULL
treatment	NULL
depended	NULL
upon	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
Stat6	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
lanes	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
or	NULL
VP-16	NULL
(	NULL
lane	NULL
14	NULL
)	NULL
.	NULL

Only	NULL
weak	NULL
or	NULL
no	NULL
transactivation	NULL
was	NULL
observed	NULL
with	NULL
MGF-Stat5a	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
MGF-Stat5a	NULL
A750	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
StatSa	NULL
A750-Stat6-792-847	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

The	NULL
transactivation	NULL
potentials	NULL
of	NULL
Stat5-Stat6	NULL
fusion	NULL
proteins	NULL
confirm	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
GAL4-Stat6	NULL
fusion	NULL
proteins	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
the	NULL
Stat6	NULL
transactivation	NULL
domain	NULL
causes	NULL
a	NULL
higher	NULL
induction	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
than	NULL
the	NULL
Stat5	NULL
transactivation	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
this	NULL
effect	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
or	NULL
it	NULL
extends	NULL
to	NULL
other	NULL
target	NULL
genes	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
CIS	NULL
and	NULL
OSM	NULL
gene	NULL
promoters	NULL
(	NULL
77	NULL
,	NULL
78	NULL
)	NULL
achieved	NULL
with	NULL
Stat5	NULL
and	NULL
Stat5aA750-Stat6-677-847	NULL
.	NULL

Transient	NULL
transfections	NULL
of	NULL
MGF-StatSa	NULL
,	NULL
StatS5aA750-Stat6-677-847	NULL
,	NULL
the	NULL
prolactin	NULL
receptor	NULL
,	NULL
and	NULL
B-casein	NULL
,	NULL
CIS	NULL
,	NULL
and	NULL
OSM	NULL
gene	NULL
promoter	NULL
constructs	NULL
were	NULL
performed	NULL
with	NULL
COS7	NULL
cells	NULL
;	NULL
cell	NULL
extracts	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
determined	NULL
.	NULL

For	NULL
all	NULL
three	NULL
reporter	NULL
constructs	NULL
,	NULL
the	NULL
inducibility	NULL
by	NULL
the	NULL
Stat5-Stat6	NULL
chimeric	NULL
factor	NULL
was	NULL
3672	NULL
MORIGGL	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
aa	NULL
1	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

a	NULL
,	NULL
n-	NULL
MGF-Statba	NULL
aa	NULL
1	NULL
a	NULL
,	NULL
n-	NULL
MGF-Stat5ba	NULL
«	NULL
750	NULL
aa	NULL
I	NULL
,	NULL
y	NULL
-h-Staté	NULL
aa	NULL
1	NULL
HN-	NULL
Statba,750/Stat6-677-847	NULL
694	NULL
750/677	NULL
aa	NULL
1	NULL
Stat5ba,750/Stat6-705-847	NULL
aa	NULL
1	NULL
N	NULL
604	NULL
7507754	NULL
aa	NULL
I	NULL
750/792	NULL
aa	NULL
1	NULL
``	NULL
N-	NULL
694	NULL
g	NULL
722	NULL
¢	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Expression	NULL
and	NULL
activation	NULL
of	NULL
Stat5-Stat6	NULL
transactivation	NULL
domain	NULL
fusion	NULL
proteins	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Structures	NULL
of	NULL
StatSa	NULL
,	NULL
Stat5aA750	NULL
(	NULL
lacking	NULL
the	NULL
Stats	NULL
transactivation	NULL
domain	NULL
)	NULL
,	NULL
Stat6	NULL
,	NULL
and	NULL
Stat5-Stat6	NULL
transactivation	NULL
domain	NULL
fusion	NULL
proteins	NULL
.	NULL

Amino	NULL
acid	NULL
(	NULL
aa	NULL
)	NULL
positions	NULL
,	NULL
SH2	NULL
domains	NULL
,	NULL
and	NULL
tyrosine	NULL
residue	NULL
694	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
which	NULL
is	NULL
essential	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
are	NULL
indicated	NULL
.	NULL

Arrows	NULL
mark	NULL
the	NULL
junction	NULL
between	NULL
Stat5-	NULL
and	NULL
Staté-specific	NULL
sequences	NULL
.	NULL

Stat5SaA750-VP16-411-489	NULL
contains	NULL
amino	NULL
acids	NULL
411	NULL
to	NULL
489	NULL
of	NULL
the	NULL
viral	NULL
transactivator	NULL
VP16	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
Stat5-Stat6	NULL
transactivation	NULL
domain	NULL
fusion	NULL
proteins	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
prolactin	NULL
receptor	NULL
,	NULL
Stat5-Stat6	NULL
transactivation	NULL
domain	NULL
fusion	NULL
constructs	NULL
,	NULL
and	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
(	NULL
+	NULL
)	NULL
prolactin	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
blotted	NULL
onto	NULL
nitrocellulose	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
phosphotyrosine-specific	NULL
antibody	NULL
(	NULL
«	NULL
-PY20	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
reprobed	NULL
with	NULL
a	NULL
chicken	NULL
antiserum	NULL
specific	NULL
for	NULL
Stat6	NULL
(	NULL
633-837	NULL
)	NULL
[	NULL
«	NULL
-Stat6	NULL
(	NULL
633-837	NULL
)	NULL
]	NULL
.	NULL

(	NULL
C	NULL
)	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
Stat5-Stat6	NULL
transactivation	NULL
domain	NULL
fusion	NULL
proteins	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
B.	NULL
Bandshift	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
proximal	NULL
B-casein	NULL
promoter	NULL
Stat	NULL
binding	NULL
site	NULL
served	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

A	NULL
Stat6é-specific	NULL
antiserum	NULL
was	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
in	NULL
supershift	NULL
experiments	NULL
.	NULL

about	NULL
fourfold	NULL
higher	NULL
than	NULL
the	NULL
induction	NULL
observed	NULL
with	NULL
StatSa	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

DISCUSSION	NULL
IL-4	NULL
is	NULL
a	NULL
cytokine	NULL
important	NULL
for	NULL
the	NULL
differentiation	NULL
and	NULL
proliferation	NULL
of	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
8	NULL
,	NULL
53	NULL
,	NULL
54	NULL
,	NULL
72	NULL
)	NULL
.	NULL

In	NULL
human	NULL
lymphocytes	NULL
,	NULL
IL-4	NULL
induction	NULL
was	NULL
shown	NULL
to	NULL
activate	NULL
Jak1	NULL
and	NULL
Jak3	NULL
(	NULL
28	NULL
,	NULL
39	NULL
)	NULL
.	NULL

IL-4	NULL
exerts	NULL
part	NULL
of	NULL
its	NULL
function	NULL
through	NULL
Stat6	NULL
,	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

Stat6	NULL
was	NULL
originally	NULL
characterized	NULL
as	NULL
a	NULL
specific	NULL
mediator	NULL
of	NULL
IL-4-dependent	NULL
gene	NULL
transcription	NULL
(	NULL
32	NULL
,	NULL
35	NULL
,	NULL
61	NULL
)	NULL
but	NULL
can	NULL
also	NULL
be	NULL
activated	NULL
by	NULL
IL-13	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Stat6	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
lymphoid	NULL
cells	NULL
and	NULL
cultured	NULL
HC11	NULL
mammary	NULL
epithelial	NULL
cells	NULL
.	NULL

The	NULL
biological	NULL
role	NULL
of	NULL
the	NULL
IL-4-mediated	NULL
responses	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
is	NULL
not	NULL
known	NULL
.	NULL

We	NULL
observed	NULL
,	NULL
however	NULL
,	NULL
that	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
,	NULL
Stat6	NULL
causes	NULL
the	NULL
induction	NULL
of	NULL
B-casein	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
B-casein	NULL
gene	NULL
promoter	NULL
can	NULL
also	NULL
be	NULL
induced	NULL
by	NULL
Stat6	NULL
in	NULL
transfected	NULL
COS7	NULL
cells	NULL
.	NULL

For	NULL
transcriptional	NULL
induction	NULL
,	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
Stat6	NULL
,	NULL
which	NULL
is	NULL
located	NULL
within	NULL
the	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
TRANSACTIVATION	NULL
DOMAINS	NULL
OF	NULL
Stat	NULL
FACTORS	NULL
3673	NULL
&	NULL
A	NULL
A	NULL
A	NULL
m	NULL
'	NULL
o	NULL
_	NULL
4	NULL
4	NULL
4	NULL
4	NULL
Prl	NULL
[	NULL
-	NULL
1	NULL
[	NULL
-	NULL
~	NULL
+	NULL
]	NULL
11-	NULL
~	NULL
_	NULL
+¥	NULL
]	NULL
11-	NULL
+	NULL
1	NULL
[	NULL
-	NULL
+11	NULL
-	NULL
_	NULL
+1	NULL
wee	NULL
Wuz	NULL
Blot	NULL
:	NULL
o-PY20	NULL
<	NULL
amminy	NULL
«	NULL
amen	NULL
wun	NULL
,	NULL
pote	NULL
!	NULL

romagp	NULL
7	NULL
8	NULL
_	NULL
9	NULL
10	NULL
11	NULL
«	NULL
aug	NULL
*	NULL
%	NULL
Blot	NULL
:	NULL
c	NULL
--	NULL
Stat6	NULL
(	NULL
633-837	NULL
)	NULL
StatbaA750-	NULL
-	NULL
StatbaA750-	NULL
-	NULL
StatbaA750-	NULL
-	NULL
StatbaA750-	NULL
StatbaA750-Stat6-677-847	NULL
Statb-705-847	NULL
Stat6-792-847	NULL
Stat6-754-847	NULL
Stat6-677-791	NULL
|	NULL
al	NULL
[	NULL
[	NULL
B	NULL
|	NULL
Pri	NULL
-	NULL
[	NULL
+	NULL
]	NULL
+	NULL
o-Stato	NULL
(	NULL
633-837	NULL
)	NULL
[	NULL
_-	NULL
[	NULL
-	NULL
[	NULL
+	NULL
]	NULL
-	NULL
[	NULL
-	NULL
[	NULL
+	NULL
]	NULL
-|-	NULL
[	NULL
+	NULL
]	NULL
-	NULL
[	NULL
-	NULL
[	NULL
+	NULL
|	NULL
-	NULL
|	NULL
-	NULL
[	NULL
+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10111213	NULL
1415	NULL
FIG	NULL
.	NULL

7-Continued	NULL
.	NULL

carboxyl-terminal	NULL
170	NULL
amino	NULL
acids	NULL
,	NULL
is	NULL
essential	NULL
.	NULL

This	NULL
transactivation	NULL
domain	NULL
functions	NULL
independently	NULL
from	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
Stat6	NULL
and	NULL
can	NULL
be	NULL
conferred	NULL
to	NULL
the	NULL
heterologous	NULL
GALA	NULL
DNA	NULL
binding	NULL
domain	NULL
or	NULL
MGF-Stat5aA750	NULL
.	NULL

It	NULL
is	NULL
about	NULL
five	NULL
times	NULL
more	NULL
potent	NULL
in	NULL
lymphoid	NULL
cells	NULL
than	NULL
in	NULL
COS7	NULL
cells	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
strength	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
Stat5	NULL
with	NULL
that	NULL
of	NULL
Stat6	NULL
in	NULL
COS7	NULL
cells	NULL
showed	NULL
that	NULL
the	NULL
Stat6	NULL
domain	NULL
is	NULL
about	NULL
10	NULL
times	NULL
more	NULL
potent	NULL
than	NULL
is	NULL
the	NULL
Stat5	NULL
domain	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
efficient	NULL
induction	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
synergistic	NULL
action	NULL
of	NULL
Stat5	NULL
and	NULL
the	NULL
GR	NULL
(	NULL
68	NULL
)	NULL
.	NULL

These	NULL
transcription	NULL
factors	NULL
form	NULL
a	NULL
molecular	NULL
complex	NULL
(	NULL
68	NULL
)	NULL
.	NULL

StatSa	NULL
and	NULL
StatSb	NULL
contain	NULL
only	NULL
a	NULL
weak	NULL
transactivation	NULL
domain	NULL
when	NULL
tested	NULL
on	NULL
minimal	NULL
promoters	NULL
or	NULL
as	NULL
GALA-Stat5	NULL
carboxyl-terminal	NULL
fusion	NULL
proteins	NULL
(	NULL
6	NULL
,	NULL
44	NULL
)	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
the	NULL
strong	NULL
transactivation	NULL
domain	NULL
of	NULL
the	NULL
GR	NULL
ameliorates	NULL
the	NULL
action	NULL
of	NULL
Stat5	NULL
.	NULL

IL-4	NULL
induction	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
through	NULL
Stat6	NULL
is	NULL
as	NULL
efficient	NULL
as	NULL
that	NULL
through	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
prolactin	NULL
and	NULL
glucocorticoids	NULL
.	NULL

This	NULL
might	NULL
be	NULL
due	NULL
to	NULL
the	NULL
inherent	NULL
strength	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
Stat6	NULL
.	NULL

Cooperation	NULL
with	NULL
the	NULL
GR	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
Stat5	NULL
.	NULL

It	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
Stat6	NULL
.	NULL

Stat5	NULL
and	NULL
Stat6	NULL
have	NULL
the	NULL
highest	NULL
sequence	NULL
homology	NULL
among	NULL
members	NULL
of	NULL
the	NULL
Stat	NULL
gene	NULL
family	NULL
.	NULL

Since	NULL
the	NULL
carboxyl	NULL
termini	NULL
of	NULL
Stats	NULL
and	NULL
Staté	NULL
do	NULL
not	NULL
have	NULL
significant	NULL
sequence	NULL
homologies	NULL
,	NULL
we	NULL
suspect	NULL
that	NULL
other	NULL
domains	NULL
are	NULL
involved	NULL
in	NULL
GR	NULL
interactions	NULL
.	NULL

Extensive	NULL
sequence	NULL
homologies	NULL
between	NULL
Stat5	NULL
and	NULL
Stat6	NULL
are	NULL
found	NULL
in	NULL
the	NULL
remainders	NULL
of	NULL
these	NULL
molecules	NULL
.	NULL

Mikita	NULL
et	NULL
al	NULL
.	NULL

also	NULL
studied	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
h-Stat6	NULL
(	NULL
43	NULL
)	NULL
.	NULL

They	NULL
showed	NULL
that	NULL
in	NULL
vitro	NULL
DNA	NULL
binding	NULL
of	NULL
recombinant	NULL
Stat6	NULL
is	NULL
stronger	NULL
to	NULL
response	NULL
elements	NULL
with	NULL
dyad	NULL
half	NULL
sites	NULL
separated	NULL
by	NULL
4	NULL
instead	NULL
of	NULL
3	NULL
nucleotides	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
proximal	NULL
B-casein	NULL
promoter	NULL
Stat	NULL
site	NULL
,	NULL
with	NULL
dyad	NULL
half	NULL
sites	NULL
separated	NULL
by	NULL
3	NULL
nucleotides	NULL
,	NULL
also	NULL
efficiently	NULL
bound	NULL
Stat6	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Mikita	NULL
et	NULL
al	NULL
.	NULL

also	NULL
showed	NULL
that	NULL
efficient	NULL
gene	NULL
transcription	NULL
directed	NULL
by	NULL
the	NULL
IL-4	NULL
response	NULL
element	NULL
derived	NULL
from	NULL
the	NULL
immunoglobulin	NULL
germ	NULL
line	NULL
heavy-chain	NULL
g	NULL
promoter	NULL
is	NULL
dependent	NULL
on	NULL
C/EBP	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Four	NULL
C/EBP	NULL
sites	NULL
are	NULL
present	NULL
in	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
region	NULL
(	NULL
11	NULL
,	NULL
50	NULL
)	NULL
.	NULL

They	NULL
did	NULL
not	NULL
observe	NULL
transcriptional	NULL
induction	NULL
of	NULL
multimerized	NULL
Stat	NULL
response	NULL
elements	NULL
without	NULL
a	NULL
C/EBP	NULL
site	NULL
linked	NULL
to	NULL
a	NULL
TK	NULL
minimal	NULL
promoter	NULL
and	NULL
a	NULL
luciferase	NULL
gene	NULL
.	NULL

The	NULL
promoter	NULL
construct	NULL
used	NULL
in	NULL
our	NULL
study	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
retains	NULL
a	NULL
C/EBP	NULL
site	NULL
and	NULL
inducibility	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
C/EBP	NULL
family	NULL
members	NULL
to	NULL
Stat6-mediated	NULL
gene	NULL
transcription	NULL
is	NULL
complex	NULL
,	NULL
since	NULL
multiple	NULL
splice	NULL
variants	NULL
of	NULL
the	NULL
five	NULL
C/EBP	NULL
family	NULL
members	NULL
exist	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
revealed	NULL
a	NULL
role	NULL
for	NULL
C/EBP-	NULL
«	NULL
and	NULL
C/EBP-8	NULL
in	NULL
IL-4-induced	NULL
gene	NULL
transcription	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
in	NULL
COS	NULL
cells	NULL
(	NULL
81	NULL
)	NULL
.	NULL

The	NULL
domain	NULL
structures	NULL
and	NULL
localization	NULL
of	NULL
the	NULL
transactiva-	NULL
3674	NULL
MORIGGL	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
1500-	NULL
(	NULL
s-casein-pro	NULL
.	NULL
)	NULL

Stat	NULL
Stat	NULL
BoxA	NULL
BoxB	NULL
3	NULL
1000-7	NULL
2	NULL
@	NULL
o	NULL
#	NULL
©	NULL
C	NULL
o	NULL
3	NULL
0	NULL
=~	NULL
G	NULL
i	NULL
i	NULL
G	NULL
&	NULL
3	NULL
5007	NULL
o	NULL
2	NULL
3	NULL
&	NULL
®	NULL
0_	NULL
Statban750-	NULL
Statban750-Staté-754-847	NULL
|VP16-411-489	NULL
pail	NULL
-	NULL
|+	NULL
]	NULL
-|	NULL
[	NULL
+	NULL
]	NULL
-|	NULL
[	NULL
+	NULL
]	NULL
-	NULL
-	NULL
|	NULL
+	NULL
]	NULL
-	NULL
|	NULL
+	NULL
1	NULL
2	NULL
3	NULL
40	NULL
500	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
B	NULL
800	NULL
600-7	NULL
2	NULL
€	NULL
€	NULL
g	NULL
2	NULL
400-o	NULL
~	NULL
Q	NULL
-~	NULL
G	NULL
&	NULL
$	NULL
&	NULL
S	NULL
%	NULL
200-C	NULL
Statbas750-	NULL
Statban750-Staté-754-847	NULL
-	NULL
|	NULL
+	NULL
-	NULL
|	NULL
+	NULL
1°	NULL
200	NULL
3	NULL
40	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Transactivation	NULL
potentials	NULL
of	NULL
Stat5	NULL
,	NULL
Stat5A750	NULL
,	NULL
and	NULL
Stat5-Stat6	NULL
transactivation	NULL
domain	NULL
fusion	NULL
proteins	NULL
.	NULL

(	NULL
A	NULL
)	NULL
COS7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
(	NULL
B-casein-pro	NULL
.	NULL
)	NULL

-luciferase	NULL
(	NULL
Luc	NULL
)	NULL
construct	NULL
,	NULL
the	NULL
prolactin	NULL
receptor	NULL
,	NULL
the	NULL
-galactosidase	NULL
gene	NULL
,	NULL
and	NULL
wild-type	NULL
StatSa	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
StatSaA750	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
StatSaA750-Stat6-677-847	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
StatSaA750-Stat6-705-847	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
StatSaA750-Stat6-754-847	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
,	NULL
StatSaA750-Stat6-792-847	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
,	NULL
StatSaA750-Stat6-677-791	NULL
(	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
,	NULL
or	NULL
StatSaA750-VP16-411-489	NULL
(	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
.	NULL

Relative	NULL
(	NULL
rel	NULL
.	NULL
)	NULL

luciferase	NULL
activities	NULL
were	NULL
determined	NULL
after	NULL
15	NULL
h	NULL
of	NULL
prolactin	NULL
(	NULL
Prl	NULL
)	NULL
treatment	NULL
(	NULL
+	NULL
)	NULL
.	NULL

-	NULL
,	NULL
untreated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
COS7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
prolactin	NULL
receptor	NULL
,	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
,	NULL
wild-type	NULL
StatSa	NULL
,	NULL
Stat5A750	NULL
,	NULL
the	NULL
Stat5-Stat6	NULL
transactivation	NULL
domain	NULL
fusion	NULL
proteins	NULL
indicated	NULL
,	NULL
and	NULL
an	NULL
N3	NULL
(	NULL
Stat-RE	NULL
)	NULL
,	NULL
construct	NULL
with	NULL
six	NULL
Stats	NULL
binding	NULL
sites	NULL
linked	NULL
to	NULL
a	NULL
i	NULL
minimal	NULL
promoter	NULL
and	NULL
a	NULL
luciferase	NULL
gene	NULL
.	NULL

Relative	NULL
luciferase	NULL
activities	NULL
were	NULL
determined	NULL
in	NULL
extracts	NULL
from	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
and	NULL
prolactin-induced	NULL
(	NULL
+	NULL
)	NULL
cells	NULL
and	NULL
normalized	NULL
against	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Three	NULL
independent	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

tion	NULL
domains	NULL
of	NULL
Stat	NULL
proteins	NULL
have	NULL
recently	NULL
been	NULL
investigated	NULL
.	NULL

The	NULL
transactivation	NULL
domains	NULL
of	NULL
Stat2	NULL
,	NULL
Stat3	NULL
,	NULL
StatS5a	NULL
,	NULL
and	NULL
Stat5b	NULL
were	NULL
mapped	NULL
to	NULL
the	NULL
carboxyl	NULL
terminus	NULL
(	NULL
30	NULL
,	NULL
44	NULL
,	NULL
47	NULL
,	NULL
49	NULL
,	NULL
58	NULL
)	NULL
.	NULL

This	NULL
is	NULL
also	NULL
the	NULL
case	NULL
for	NULL
Stat6	NULL
.	NULL

Within	NULL
this	NULL
region	NULL
,	NULL
we	NULL
find	NULL
many	NULL
proline	NULL
,	NULL
serine	NULL
,	NULL
threonine	NULL
,	NULL
leucine	NULL
,	NULL
and	NULL
glutamine	NULL
residues	NULL
but	NULL
not	NULL
many	NULL
acidic	NULL
residues	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

This	NULL
is	NULL
indicative	NULL
of	NULL
a	NULL
nonacidic	NULL
transactivation	NULL
domain	NULL
.	NULL

Similar	NULL
characteristics	NULL
have	NULL
been	NULL
described	NULL
for	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
octamer	NULL
factors	NULL
and	NULL
steroid	NULL
hormone	NULL
receptors	NULL
(	NULL
7	NULL
,	NULL
27	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
based	NULL
on	NULL
GALA	NULL
and	NULL
StatSa	NULL
A750	NULL
fusion	NULL
proteins	NULL
indicate	NULL
that	NULL
a	NULL
central	NULL
core	NULL
region	NULL
(	NULL
amino	NULL
acids	NULL
677	NULL
to	NULL
791	NULL
[	NULL
Fig	NULL
.	NULL

10	NULL
]	NULL
)	NULL
is	NULL
important	NULL
for	NULL
transactivation	NULL
.	NULL

We	NULL
tested	NULL
several	NULL
carboxyl-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
Stat6	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Stop	NULL
codons	NULL
were	NULL
introduced	NULL
at	NULL
amino	NULL
acids	NULL
positions	NULL
677	NULL
,	NULL
705	NULL
,	NULL
754	NULL
,	NULL
and	NULL
792	NULL
of	NULL
h-Stat6	NULL
.	NULL

These	NULL
deletion	NULL
mutants	NULL
were	NULL
analyzed	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
DNA	NULL
binding	NULL
,	NULL
and	NULL
transactivation	NULL
potential	NULL
upon	NULL
IL-4	NULL
induction	NULL
.	NULL

All	NULL
variants	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
able	NULL
to	NULL
specifically	NULL
bind	NULL
DNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
deletion	NULL
mutant	NULL
h-Stat6A677	NULL
lacked	NULL
the	NULL
ability	NULL
to	NULL
transactivate	NULL
efficiently	NULL
.	NULL

This	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
A	NULL
(	NULL
s-casein-pro	NULL
.	NULL
)	NULL

«	NULL
344	NULL
-144	NULL
-i34-97	NULL
-89	NULL
<	NULL
1	NULL
.	NULL

350	NULL
7	NULL
3007	NULL
250	NULL
7	NULL
b	NULL
I	NULL
&	NULL
l	NULL
1	NULL
150	NULL
100	NULL
rel	NULL
.	NULL

luciferase	NULL
activity	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
MGF-StatSa	NULL
Statban750-Stat6-677-847	NULL
B-cas-Luc	NULL
.	NULL

CIS-Luc	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
(	NULL
CIS-pro	NULL
.	NULL
)	NULL

100	NULL
50	NULL
TRANSACTIVATION	NULL
DOMAINS	NULL
OF	NULL
Stat	NULL
FACTORS	NULL
-	NULL
3675	NULL
(	NULL
OSM-pro	NULL
.	NULL
)	NULL

-662	NULL
-188	NULL
94	NULL
+48	NULL
00000	NULL
-179-103	NULL
150	NULL
q	NULL
100-7	NULL
50	NULL
0	NULL
OSM-Luc	NULL
.	NULL

1	NULL
2	NULL
3	NULL
45	NULL
6	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
Stats	NULL
and	NULL
Stat6	NULL
transactivation	NULL
domains	NULL
and	NULL
their	NULL
effects	NULL
on	NULL
B-casein	NULL
(	NULL
B-cas	NULL
)	NULL
(	NULL
A	NULL
)	NULL
,	NULL
CIS	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
OSM	NULL
(	NULL
C	NULL
)	NULL
gene	NULL
promoters	NULL
(	NULL
pro	NULL
.	NULL
)	NULL

.	NULL

COS7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
MGF-Stat5a	NULL
,	NULL
StatSaA750-Stat6-677-847	NULL
,	NULL
the	NULL
prolactin	NULL
receptor	NULL
,	NULL
and	NULL
the	NULL
reporter	NULL
constructs	NULL
indicated	NULL
.	NULL

The	NULL
numbering	NULL
refers	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
sites	NULL
in	NULL
individual	NULL
genes	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
Stat	NULL
boxes	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
-galactosidase	NULL
gene	NULL
was	NULL
included	NULL
to	NULL
monitor	NULL
transfection	NULL
efficiency	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
prolactin	NULL
(	NULL
Prl	NULL
)	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
relative	NULL
(	NULL
rel	NULL
.	NULL
)	NULL

luciferase	NULL
(	NULL
Luc	NULL
.	NULL
)	NULL

activities	NULL
were	NULL
determined	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
were	NULL
normalized	NULL
against	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

Three	NULL
individual	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

deletion	NULL
mutant	NULL
is	NULL
similar	NULL
to	NULL
h-Stat6A661	NULL
(	NULL
43	NULL
)	NULL
.	NULL

It	NULL
is	NULL
a	NULL
potent	NULL
dominant	NULL
negative	NULL
variant	NULL
and	NULL
suppresses	NULL
the	NULL
activity	NULL
of	NULL
endogenous	NULL
Stat6	NULL
in	NULL
HepG2	NULL
cells	NULL
activated	NULL
by	NULL
IL-4	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
Stat5	NULL
is	NULL
important	NULL
for	NULL
downregulation	NULL
of	NULL
DNA	NULL
binding	NULL
by	NULL
tyrosine	NULL
dephosphorylation	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
Stat6	NULL
deletion	NULL
mutants	NULL
were	NULL
also	NULL
analyzed	NULL
for	NULL
their	NULL
DNA	NULL
binding	NULL
kinetics	NULL
after	NULL
IL-4	NULL
activation	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
observations	NULL
made	NULL
with	NULL
Stat5	NULL
variants	NULL
,	NULL
a	NULL
deletion	NULL
of	NULL
93	NULL
,	NULL
142	NULL
,	NULL
or	NULL
170	NULL
amino	NULL
acids	NULL
of	NULL
h-Stat6	NULL
resulted	NULL
in	NULL
impaired	NULL
downregulation	NULL
and	NULL
prolonged	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
a	NULL
delay	NULL
in	NULL
the	NULL
downregulation	NULL
of	NULL
DNA	NULL
binding	NULL
with	NULL
constructs	NULL
Stat	NULL
SaA750	NULL
and	NULL
StatSaA750-Stat6-792-847	NULL
.	NULL

Constructs	NULL
StatSaA	NULL
750-Stat6-677-847	NULL
,	NULL
StatSaA750-Stat6-705-847	NULL
,	NULL
StatSaA750-Stat	NULL
6-677-847	NULL
,	NULL
and	NULL
StatSa	NULL
A750-Stat6-677-791	NULL
showed	NULL
wild-type	NULL
behavior	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

From	NULL
the	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
region	NULL
between	NULL
amino	NULL
acids	NULL
754	NULL
and	NULL
792	NULL
of	NULL
h-Stat6	NULL
is	NULL
important	NULL
for	NULL
the	NULL
downregulation	NULL
of	NULL
DNA	NULL
binding	NULL
through	NULL
tyrosine	NULL
dephosphorylation	NULL
.	NULL

A	NULL
remarkable	NULL
feature	NULL
of	NULL
the	NULL
Stat6	NULL
transactivation	NULL
domain	NULL
is	NULL
the	NULL
cell	NULL
type	NULL
dependence	NULL
of	NULL
its	NULL
efficiency	NULL
.	NULL

The	NULL
GAL4-Stat6	NULL
fusion	NULL
was	NULL
active	NULL
in	NULL
both	NULL
COS7	NULL
and	NULL
Ba/F3	NULL
cells	NULL
but	NULL
was	NULL
much	NULL
stronger	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Studies	NULL
of	NULL
the	NULL
interactions	NULL
of	NULL
the	NULL
Stat6	NULL
transactivation	NULL
domain	NULL
with	NULL
cell	NULL
type-specific	NULL
coactiva-tors	NULL
,	NULL
corepressors	NULL
,	NULL
and	NULL
components	NULL
of	NULL
the	NULL
basal	NULL
transcription	NULL
initiation	NULL
complex	NULL
might	NULL
be	NULL
interesting	NULL
in	NULL
this	NULL
context	NULL
.	NULL

A	NULL
second	NULL
interesting	NULL
feature	NULL
of	NULL
the	NULL
Stat6	NULL
transactivation	NULL
domain	NULL
concerns	NULL
autonomous	NULL
regulation	NULL
through	NULL
IL-4	NULL
.	NULL

Although	NULL
GALA4-Stat6	NULL
transactivation	NULL
domain	NULL
constructs	NULL
exhibit	NULL
high	NULL
constitutive	NULL
activities	NULL
,	NULL
they	NULL
still	NULL
can	NULL
be	NULL
enhanced	NULL
by	NULL
the	NULL
action	NULL
of	NULL
IL-4	NULL
.	NULL

The	NULL
transactivation	NULL
domain	NULL
is	NULL
rich	NULL
in	NULL
serine	NULL
and	NULL
threonine	NULL
residues	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
the	NULL
enhanced	NULL
activity	NULL
of	NULL
the	NULL
Stat6	NULL
transactivation	NULL
domain	NULL
upon	NULL
IL-4	NULL
stimulation	NULL
is	NULL
correlated	NULL
with	NULL
phosphorylation	NULL
events	NULL
in	NULL
this	NULL
region	NULL
.	NULL

Mitogen-activated	NULL
protein	NULL
kinase	NULL
activity	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
increased	NULL
after	NULL
IL-4R	NULL
activation	NULL
in	NULL
human	NULL
keratinocytes	NULL
(	NULL
75	NULL
)	NULL
.	NULL

Serine	NULL
or	NULL
threonine	NULL
phosphorylation	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
Stat1-	NULL
,	NULL
Stat3-	NULL
,	NULL
and	NULL
Stat5-DNA	NULL
complexes	NULL
(	NULL
5	NULL
,	NULL
74	NULL
,	NULL
80	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
Stat1	NULL
and	NULL
Stat3	NULL
was	NULL
ascribed	NULL
to	NULL
the	NULL
action	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
74	NULL
,	NULL
80	NULL
)	NULL
.	NULL

This	NULL
enzyme	NULL
does	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
Stat5	NULL
phosphorylation	NULL
upon	NULL
cytokine	NULL
activation	NULL
(	NULL
5	NULL
,	NULL
73	NULL
)	NULL
.	NULL

No	NULL
cytokine	NULL
dependence	NULL
of	NULL
the	NULL
Stat5	NULL
transactivation	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
in	NULL
Ba/F3-PR	NULL
cells	NULL
upon	NULL
prolactin	NULL
or	NULL
interleukin-3	NULL
activation	NULL
was	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
efficient	NULL
transcription	NULL
from	NULL
the	NULL
B-casein	NULL
promoter	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
Ba/F3	NULL
cells	NULL
stimulated	NULL
with	NULL
prolactin	NULL
,	NULL
IL-3	NULL
,	NULL
or	NULL
IL-4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Stat5	NULL
or	NULL
Stat6	NULL
activation	NULL
is	NULL
not	NULL
a	NULL
sufficient	NULL
requirement	NULL
for	NULL
transcriptional	NULL
induction	NULL
.	NULL

This	NULL
is	NULL
different	NULL
from	NULL
an	NULL
artificial	NULL
construct	NULL
which	NULL
contains	NULL
multimerized	NULL
Stat	NULL
binding	NULL
sites	NULL
in	NULL
its	NULL
promoter	NULL
region	NULL
(	NULL
44	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
B-casein	NULL
gene	NULL
promoter	NULL
has	NULL
a	NULL
modular	NULL
design	NULL
and	NULL
contains	NULL
multiple	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
Stat	NULL
sites	NULL
(	NULL
14	NULL
,	NULL
18	NULL
,	NULL
57	NULL
,	NULL
64	NULL
)	NULL
.	NULL

3676	NULL
MORIGGL	NULL
ET	NULL
AL	NULL
.	NULL

k	NULL
h-Stat6a661	NULL
h-Stat6	NULL
(	NULL
aa	NULL
641	NULL
)	NULL
m-Stat6	NULL
(	NULL
aa	NULL
641	NULL
)	NULL
h-Stat6	NULL
(	NULL
aa	NULL
703	NULL
)	NULL
m-Stat6	NULL
(	NULL
aa	NULL
696	NULL
)	NULL
h-Stat6	NULL
(	NULL
aa	NULL
765	NULL
)	NULL
m-Stat6	NULL
(	NULL
aa	NULL
756	NULL
)	NULL
h-Stat6	NULL
(	NULL
aa	NULL
827	NULL
)	NULL
m-Stat6	NULL
(	NULL
aa	NULL
817	NULL
)	NULL
VPATIKMIVERDQPLPTPELOMPTMVPSYDLCMAP	NULL
VSTTIEMTVERDQPLPTPEPQMPAMVPPYDLCMAP	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

h-Stat6a677	NULL
h-Stat6a7	NULL
92	NULL
I	NULL
SEDMYFPLLPPTEQDLTKLLLENQGEGGG_SLGSQPLLKPS	NULL
HYGQOSCI	NULL
SMSHMDLRANPSW	NULL
(	NULL
aa	NULL
847	NULL
)	NULL
PYGOSCISLSHLDLRTNPSW	NULL
(	NULL
aa	NULL
837	NULL
)	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Sequence	NULL
alignment	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
transactivation	NULL
domains	NULL
of	NULL
murine	NULL
(	NULL
m-Stat6	NULL
)	NULL
(	NULL
48	NULL
)	NULL
and	NULL
h-Stat6	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Proline	NULL
,	NULL
serine	NULL
,	NULL
threonine	NULL
,	NULL
leucine	NULL
,	NULL
and	NULL
glutamine	NULL
amino	NULL
acids	NULL
are	NULL
in	NULL
boldface	NULL
.	NULL

They	NULL
could	NULL
be	NULL
important	NULL
for	NULL
the	NULL
nonacidic	NULL
transactivation	NULL
domains	NULL
.	NULL

The	NULL
shaded	NULL
area	NULL
(	NULL
amino	NULL
acid	NULL
[	NULL
aa	NULL
]	NULL
positions	NULL
677	NULL
to	NULL
792	NULL
)	NULL
is	NULL
the	NULL
minimal	NULL
transactivation	NULL
domain	NULL
of	NULL
h-Stat6	NULL
defined	NULL
here	NULL
.	NULL

The	NULL
region	NULL
from	NULL
amino	NULL
acids	NULL
677	NULL
to	NULL
754	NULL
was	NULL
found	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
IL-4-mediated	NULL
regulation	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
.	NULL

The	NULL
region	NULL
from	NULL
amino	NULL
acids	NULL
754	NULL
to	NULL
792	NULL
of	NULL
h-Staté	NULL
was	NULL
found	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
the	NULL
downregulation	NULL
of	NULL
activated	NULL
Stat6	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
truncation	NULL
variants	NULL
analyzed	NULL
here	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
the	NULL
truncated	NULL
h-Stat6	NULL
variant	NULL
described	NULL
by	NULL
Mikita	NULL
et	NULL
al	NULL
.	NULL

(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
accession	NULL
numbers	NULL
of	NULL
sequences	NULL
and	NULL
the	NULL
programs	NULL
used	NULL
for	NULL
alignment	NULL
are	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

CCAAT	NULL
family	NULL
members	NULL
also	NULL
were	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
multiple	NULL
sites	NULL
within	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
close	NULL
to	NULL
the	NULL
two	NULL
Stat	NULL
sites	NULL
(	NULL
11	NULL
,	NULL
50	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
repressor	NULL
sites	NULL
bind	NULL
factors	NULL
like	NULL
C/EBP	NULL
-B	NULL
,	NULL
C/EBP	NULL
-y	NULL
,	NULL
YY1	NULL
,	NULL
and	NULL
SBP	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
42	NULL
)	NULL
.	NULL

These	NULL
repressors	NULL
might	NULL
not	NULL
be	NULL
relieved	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
superimposing	NULL
an	NULL
additional	NULL
layer	NULL
of	NULL
regulation	NULL
to	NULL
the	NULL
Jak-Stat	NULL
pathway	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
E.	NULL
Greiner	NULL
,	NULL
J.	NULL
Fominaya	NULL
,	NULL
A.	NULL
Duschl	NULL
,	NULL
and	NULL
R.	NULL
Schiile	NULL
for	NULL
plasmids	NULL
and	NULL
reagents	NULL
and	NULL
C.	NULL
Beisenherz	NULL
,	NULL
M.	NULL
Fritsche	NULL
,	NULL
R.	NULL
Ji	NULL
&	NULL
hne	NULL
,	NULL
and	NULL
E.	NULL
Pfitzner	NULL
(	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
,	NULL
Tumor	NULL
Biology	NULL
Center	NULL
)	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

The	NULL
h-Stat6	NULL
plasmid	NULL
was	NULL
from	NULL
J.	NULL
Hou	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
(	NULL
San	NULL
Francisco	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
OSM	NULL
and	NULL
CIS	NULL
reporter	NULL
gene	NULL
constructs	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
A.	NULL
Miyajima	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-4	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
W.	NULL
Sebald	NULL
(	NULL
Wiirzburg	NULL
,	NULL
Ger-many	NULL
)	NULL
.	NULL

We	NULL
thank	NULL
I.	NULL
Dusanter-Fourt	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
for	NULL
providing	NULL
Ba/	NULL
F3-PR	NULL
cells	NULL
,	NULL
A.	NULL
Lischke	NULL
(	NULL
Wiirzburg	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
providing	NULL
Ba/F3-ILAR	NULL
cells	NULL
,	NULL
and	NULL
Ines	NULL
Fernandez	NULL
(	NULL
Freiburg	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
providing	NULL
editorial	NULL
assistance	NULL
.	NULL

KF	NULL
.	NULL

and	NULL
W.K	NULL
.	NULL

were	NULL
supported	NULL
by	NULL
Deutsche	NULL
Forschungsgemein-schaft	NULL
grant	NULL
SFB	NULL
176	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Altick	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1993	NULL
.	NULL

Interaction	NULL
of	NULL
two	NULL
sequence-specific	NULL
single-stranded	NULL
DNA-binding	NULL
proteins	NULL
with	NULL
an	NULL
essential	NULL
region	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
is	NULL
regulated	NULL
by	NULL
lactogenic	NULL
hormones	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7303-7310	NULL
.	NULL

2	NULL
.	NULL

Altick	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1994	NULL
.	NULL

B-Cascin	NULL
mRNA	NULL
sequesters	NULL
a	NULL
single-stranded	NULL
nucleic	NULL
acid-binding	NULL
protein	NULL
which	NULL
negatively	NULL
regulates	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6004-6012	NULL
.	NULL

3	NULL
.	NULL

Azam	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
B.	NULL
L.	NULL
Kreider	NULL
,	NULL
M.	NULL
Xia	NULL
,	NULL
F.	NULL
Quelle	NULL
,	NULL
R.	NULL
Basu	NULL
,	NULL
C.	NULL
Saris	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
J.	NULL
N.	NULL
Ihle	NULL
,	NULL
and	NULL
C.	NULL
Schindler	NULL
.	NULL

1995	NULL
.	NULL

Interleukin-3	NULL
signals	NULL
through	NULL
multiple	NULL
isoforms	NULL
of	NULL
Stat5	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1402-1411	NULL
.	NULL

4	NULL
.	NULL

Ball	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
R.	NULL
R.	NULL
Friis	NULL
,	NULL
C.-A	NULL
.	NULL

Schoenenberger	NULL
,	NULL
W.	NULL
Doppler	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1988	NULL
.	NULL

Prolactin	NULL
regulation	NULL
of	NULL
the	NULL
B-casein	NULL
expression	NULL
and	NULL
of	NULL
a	NULL
cytosolic	NULL
120-kd	NULL
protein	NULL
in	NULL
a	NULL
cloned	NULL
mouse	NULL
mammary	NULL
epithelial	NULL
cell	NULL
line	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:2089-2095	NULL
.	NULL

5	NULL
.	NULL

Beadling	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Ng	NULL
,	NULL
J.	NULL
W.	NULL
Babbage	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-2	NULL
activation	NULL
of	NULL
Stat5	NULL
requires	NULL
the	NULL
convergent	NULL
action	NULL
of	NULL
tyrosine	NULL
kinases	NULL
and	NULL
a	NULL
serine/threonine	NULL
kinase	NULL
pathway	NULL
distinct	NULL
from	NULL
the	NULL
Rafl/ERK2	NULL
MAP	NULL
kinase	NULL
pathway	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:1902-1913	NULL
.	NULL

6	NULL
.	NULL

Berchtold	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Moriggl	NULL
,	NULL
F.	NULL
Gouilleux	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

Cytokine	NULL
receptor	NULL
independent	NULL
,	NULL
constitutively	NULL
active	NULL
variants	NULL
of	NULL
Stat5	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

7	NULL
.	NULL

Chi	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
Liebermann	NULL
,	NULL
K.	NULL
Ellwood	NULL
,	NULL
and	NULL
M.	NULL
Carey	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
general	NULL
mechanism	NULL
for	NULL
transcriptional	NULL
synergy	NULL
by	NULL
eukaryotic	NULL
activators	NULL
.	NULL

Nature	NULL
377:254-257	NULL
.	NULL

8	NULL
.	NULL

Delphin	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
Staynezer	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
interleukin	NULL
4	NULL
(	NULL
IL-4	NULL
)	NULL
responsive	NULL
region	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
germline	NULL
e	NULL
promoter	NULL
:	NULL
regulation	NULL
by	NULL
NF-IL-4	NULL
,	NULL
a	NULL
C/EBP	NULL
family	NULL
member	NULL
and	NULL
NF-	NULL
«	NULL
B/p50	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:181-192	NULL
.	NULL

9	NULL
.	NULL

Deutsch	NULL
,	NULL
H.	NULL
H.	NULL
J.	NULL
,	NULL
K.	NULL
Koettnitz	NULL
,	NULL
J.	NULL
Chung	NULL
,	NULL
and	NULL
F.	NULL
S.	NULL
Kalthoff	NULL
.	NULL

1995	NULL
.	NULL

Distinct	NULL
sequence	NULL
motifs	NULL
within	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
receptor	NULL
differentially	NULL
regulate	NULL
apoptosis	NULL
inhibition	NULL
and	NULL
cell	NULL
growth	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154	NULL
:	NULL
3696-3703	NULL
.	NULL

10	NULL
.	NULL

Doppler	NULL
,	NULL
W.	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
and	NULL
R.	NULL
K.	NULL
Ball	NULL
.	NULL

1989	NULL
.	NULL

Prolactin	NULL
and	NULL
glucocorticoid	NULL
hormones	NULL
synergistically	NULL
induce	NULL
expression	NULL
of	NULL
transfected	NULL
rat	NULL
B-cascin	NULL
gene	NULL
promoter	NULL
constructs	NULL
in	NULL
a	NULL
mammary	NULL
epithelial	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:104-108	NULL
.	NULL

11	NULL
.	NULL

Doppler	NULL
,	NULL
W.	NULL
,	NULL
T.	NULL
Welte	NULL
,	NULL
and	NULL
S.	NULL
Philipp	NULL
.	NULL

1995	NULL
.	NULL

CCAAT/enhancer-binding	NULL
protein	NULL
isoforms	NULL
b	NULL
and	NULL
d	NULL
are	NULL
expressed	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
and	NULL
bind	NULL
to	NULL
multiple	NULL
sites	NULL
in	NULL
the	NULL
B-casein	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:17962-17969	NULL
.	NULL

12	NULL
.	NULL

Dusanter-Fourt	NULL
,	NULL
L.	NULL
,	NULL
O.	NULL
Muller	NULL
,	NULL
A.	NULL
Ziemiecki	NULL
,	NULL
P.	NULL
Mayeux	NULL
,	NULL
B.	NULL
Drucker	NULL
,	NULL
J.	NULL
Djiane	NULL
,	NULL
A.	NULL
Wilks	NULL
,	NULL
A.	NULL
G.	NULL
Harpur	NULL
,	NULL
S.	NULL
Fisher	NULL
,	NULL
and	NULL
S.	NULL
Gisselbrecht	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
Jak	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
as	NULL
signaling	NULL
molecules	NULL
for	NULL
PRL	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
PRL	NULL
receptor	NULL
and	NULL
PRL-erythropoictin	NULL
receptor	NULL
chimera	NULL
expressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:2583-2591	NULL
.	NULL

13	NULL
.	NULL

Duschl	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
Sebald	NULL
.	NULL

Transmembrane	NULL
and	NULL
intracellular	NULL
signaling	NULL
by	NULL
interleukin-4	NULL
:	NULL
receptor	NULL
dimerization	NULL
and	NULL
beyond	NULL
.	NULL

Eur	NULL
.	NULL

Cytokine	NULL
Netw	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

14	NULL
.	NULL

Gouilleux	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1995	NULL
.	NULL

Prolactin-mediated	NULL
gene	NULL
activation	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

5587-594	NULL
.	NULL

15	NULL
.	NULL

Gouilleux	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
Wakao	NULL
,	NULL
M.	NULL
Mundt	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1994	NULL
.	NULL

Prolactin	NULL
induces	NULL
phosphorylation	NULL
of	NULL
tyr694	NULL
of	NULL
StatS	NULL
(	NULL
MGF	NULL
)	NULL
,	NULL
a	NULL
prerequisite	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
induction	NULL
of	NULL
transcription	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4361-4369	NULL
.	NULL

16	NULL
.	NULL

Gouilleux	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Pallard	NULL
,	NULL
I.	NULL
Dusanter-Fourt	NULL
,	NULL
H.	NULL
Wakao	NULL
,	NULL
L.-A	NULL
.	NULL

Haldosen	NULL
,	NULL
G.	NULL
Norstedt	NULL
,	NULL
D.	NULL
Levy	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1995	NULL
.	NULL

Prolactin	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
erythropoietin	NULL
and	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
induce	NULL
MGF-Stat5	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2005-2013	NULL
.	NULL

17	NULL
.	NULL

Gouilleux	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Moritz	NULL
,	NULL
M.	NULL
Humar	NULL
,	NULL
R.	NULL
Moriggl	NULL
,	NULL
S.	NULL
Berchtold	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1995	NULL
.	NULL

Prolactin	NULL
and	NULL
interleukin	NULL
2	NULL
receptors	NULL
in	NULL
T	NULL
lymphocytes	NULL
signal	NULL
through	NULL
a	NULL
MGPF/StatS-like	NULL
transcription	NULL
factor	NULL
.	NULL

Endocrinology	NULL
136:5700-5708	NULL
.	NULL

18	NULL
.	NULL

Groner	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
Altick	NULL
,	NULL
and	NULL
V.	NULL
Meier	NULL
.	NULL

1994	NULL
.	NULL

Hormonal	NULL
regulation	NULL
of	NULL
transcription	NULL
factor	NULL
activity	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Endocrinol	NULL
.	NULL

100	NULL
:	NULL
109-114	NULL
.	NULL

19	NULL
.	NULL

Grusby	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
S.	NULL
C.	NULL
Mitchell	NULL
,	NULL
N.	NULL
Nabavi	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1990	NULL
.	NULL

Casein	NULL
expression	NULL
in	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:6897-6901	NULL
.	NULL

20	NULL
.	NULL

Harada	NULL
,	NULL
N.	NULL
,	NULL
G.	NULL
Yang	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
and	NULL
M.	NULL
Howard	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
essential	NULL
region	NULL
for	NULL
growth	NULL
signal	NULL
transduction	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
interleukin-4	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:22752-22758	NULL
.	NULL

21	NULL
.	NULL

Heim	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

Contribution	NULL
of	NULL
Stat	NULL
SH2	NULL
groups	NULL
to	NULL
specific	NULL
interferon	NULL
signaling	NULL
by	NULL
the	NULL
Jak-Stat	NULL
pathway	NULL
.	NULL

Science	NULL
267:1347-1349	NULL
.	NULL

22	NULL
.	NULL

Heim	NULL
,	NULL
M.	NULL
H.	NULL
1996	NULL
.	NULL

The	NULL
Jak-Stat	NULL
pathway	NULL
:	NULL
specific	NULL
signal	NULL
transduction	NULL
from	NULL
the	NULL
cell	NULL
membrane	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

26:1-12	NULL
.	NULL

23	NULL
.	NULL

Horvarth	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Z.	NULL
Wen	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
Stat	NULL
protein	NULL
domain	NULL
that	NULL
determines	NULL
DNA	NULL
sequence	NULL
recognition	NULL
suggests	NULL
a	NULL
novel	NULL
DNA-binding	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:984-994	NULL
.	NULL

24	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
T.	NULL
C.	NULL
Ho	NULL
,	NULL
M.	NULL
Brasseur	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
:	NULL
IL-4	NULL
Stat	NULL
.	NULL

Science	NULL
265:1701-1706	NULL
.	NULL

25	NULL
.	NULL

Hou	NULL
,	NULL
X.	NULL
S.	NULL
,	NULL
M.	NULL
B.	NULL
Melnick	NULL
,	NULL
and	NULL
N.	NULL
Perrimon	NULL
.	NULL

1996	NULL
.	NULL

Marelle	NULL
acts	NULL
downstream	NULL
of	NULL
the	NULL
Drosophila	NULL
HOP/JAK	NULL
kinase	NULL
and	NULL
encodes	NULL
a	NULL
protein	NULL
similar	NULL
to	NULL
the	NULL
mammalian	NULL
STAT	NULL
's	NULL
.	NULL

Cell	NULL
84:411-419	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

Thile	NULL
,	NULL
J.	NULL
N.	NULL
1996	NULL
.	NULL

Stats	NULL
:	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

Cell	NULL
84:331-334	NULL
.	NULL

Jacq	NULL
,	NULL
X.	NULL
,	NULL
C.	NULL
Bou	NULL
,	NULL
Y.	NULL
Lutz	NULL
,	NULL
I.	NULL
Davidson	NULL
,	NULL
P.	NULL
Chambon	NULL
,	NULL
and	NULL
L.	NULL
Tora	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
TAFII30	NULL
is	NULL
present	NULL
in	NULL
a	NULL
distinct	NULL
TFIID	NULL
complex	NULL
and	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
estrogen	NULL
receptor	NULL
.	NULL

Cell	NULL
79:107-117	NULL
.	NULL

Kammer	NULL
,	NULL
W.	NULL
,	NULL
A.	NULL
Lischke	NULL
,	NULL
R.	NULL
Moriggl	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
A.	NULL
Ziemiecki	NULL
,	NULL
C.	NULL
B.	NULL
Gur-niak	NULL
,	NULL
L.	NULL
J.	NULL
Berg	NULL
,	NULL
and	NULL
K.	NULL
Friedrich	NULL
.	NULL

1996	NULL
.	NULL

Homodimerization	NULL
of	NULL
interleukin-4	NULL
receptor	NULL
a	NULL
chain	NULL
can	NULL
induce	NULL
intracellular	NULL
signalling	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
23634-23637	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
S.	NULL
T.	NULL
Smiley	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Grusby	NULL
.	NULL

1996	NULL
.	NULL

Stat6	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
responses	NULL
to	NULL
IL-4	NULL
and	NULL
for	NULL
the	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

Immunity	NULL
4:313-319	NULL
.	NULL

Kaptein	NULL
,	NULL
A.	NULL
,	NULL
V.	NULL
Paillard	NULL
,	NULL
and	NULL
M.	NULL
Saunders	NULL
.	NULL

1996	NULL
.	NULL

Dominant	NULL
negative	NULL
Stat3	NULL
mutant	NULL
inhibits	NULL
interleukin-6-induced	NULL
Jak-Stat	NULL
signal	NULL
transduction	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:5961-5964	NULL
.	NULL

Kazansky	NULL
,	NULL
A.	NULL
V.	NULL
,	NULL
B.	NULL
Raught	NULL
,	NULL
M.	NULL
Lindsey	NULL
,	NULL
Y.	NULL
Wang	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Rosen	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
mammary	NULL
gland	NULL
factor/Stat5a	NULL
during	NULL
mammary	NULL
gland	NULL
development	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

91598-1609	NULL
.	NULL

Kohler	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
Rieber	NULL
.	NULL

1993	NULL
.	NULL

Allergy-associated	NULL
le	NULL
and	NULL
Foe	NULL
receptor	NULL
II	NULL
(	NULL
CD23b	NULL
)	NULL
genes	NULL
activated	NULL
via	NULL
binding	NULL
of	NULL
an	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
to	NULL
a	NULL
novel	NULL
responsive	NULL
element	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:3066-3071	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
S.	NULL
Watanabe	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1993	NULL
.	NULL

Sharing	NULL
of	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
receptor	NULL
y	NULL
chain	NULL
between	NULL
receptors	NULL
for	NULL
IL-2	NULL
and	NULL
IL-4	NULL
.	NULL

Nature	NULL
262:1874-1877	NULL
.	NULL

Kopf	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Gros	NULL
,	NULL
M.	NULL
Bachmann	NULL
,	NULL
M.	NULL
C.	NULL
Lamers	NULL
,	NULL
H.	NULL
Bluethmann	NULL
,	NULL
and	NULL
G.	NULL
Kohler	NULL
.	NULL

1993	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
blocks	NULL
Th2	NULL
cytokine	NULL
response	NULL
.	NULL

Nature	NULL
362:245-248	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
N.	NULL
C.	NULL
Reich	NULL
.	NULL

1993	NULL
.	NULL

Requirement	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
for	NULL
rapid	NULL
activation	NULL
of	NULL
a	NULL
DNA	NULL
binding	NULL
factor	NULL
by	NULL
IL-4	NULL
.	NULL

Science	NULL
262	NULL
:	NULL
1265-1267	NULL
.	NULL

Kithn	NULL
,	NULL
R.	NULL
,	NULL
K.	NULL
Rajewsky	NULL
,	NULL
and	NULL
W.	NULL
Miiller	NULL
.	NULL

1991	NULL
.	NULL

Generation	NULL
and	NULL
analysis	NULL
of	NULL
interleukin-4	NULL
deficient	NULL
mice	NULL
.	NULL

Science	NULL
254:707-710	NULL
.	NULL

Lai	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
W.	NULL
Xu	NULL
,	NULL
S.	NULL
L.	NULL
Gaffen	NULL
,	NULL
K.	NULL
D.	NULL
Liu	NULL
,	NULL
G.	NULL
D.	NULL
Longmore	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Goldsmith	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
molecular	NULL
role	NULL
of	NULL
the	NULL
common	NULL
y	NULL
,	NULL
,	NULL
subunit	NULL
in	NULL
signal	NULL
transduction	NULL
reveals	NULL
functional	NULL
asymmetry	NULL
within	NULL
multimeric	NULL
cytokine	NULL
receptor	NULL
complexes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:231-235	NULL
.	NULL

Latchman	NULL
,	NULL
D.	NULL
S.	NULL
1995	NULL
.	NULL

Activation	NULL
and	NULL
repression	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
transcription	NULL
factors	NULL
,	NULL
p.	NULL
239-264	NULL
.	NULL

In	NULL
Eukaryotic	NULL
transcription	NULL
factors	NULL
.	NULL

Academic	NULL
Press	NULL
Ltd.	NULL
,	NULL
London	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

Lin	NULL
,	NULL
J.-X	NULL
.	NULL

,	NULL
T.-S.	NULL
Migone	NULL
,	NULL
M.	NULL
Tsang	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Wheatherbee	NULL
,	NULL
L.	NULL
Zhou	NULL
,	NULL
A.	NULL
Yamauchi	NULL
,	NULL
E.	NULL
T.	NULL
Bloom	NULL
,	NULL
J.	NULL
Mictz	NULL
,	NULL
S.	NULL
John	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
role	NULL
of	NULL
shared	NULL
receptor	NULL
motifs	NULL
and	NULL
common	NULL
Stat	NULL
proteins	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cytokine	NULL
pleiotropy	NULL
and	NULL
redundancy	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-13	NULL
and	NULL
IL-15	NULL
.	NULL

Immunity	NULL
2331-339	NULL
.	NULL

Lischke	NULL
,	NULL
A.	NULL
,	NULL
W.	NULL
Kammer	NULL
,	NULL
and	NULL
K.	NULL
Friedrich	NULL
.	NULL

1995	NULL
.	NULL

Different	NULL
human	NULL
interleukin-4	NULL
mutants	NULL
preferentially	NULL
activate	NULL
human	NULL
or	NULL
murine	NULL
common	NULL
receptor	NULL
gamma	NULL
chain	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

234:100-107	NULL
.	NULL

Liu	NULL
,	NULL
X.	NULL
,	NULL
G.	NULL
W.	NULL
Robinson	NULL
,	NULL
F.	NULL
Gouilleux	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
and	NULL
L.	NULL
Hennighausen	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
and	NULL
expression	NULL
of	NULL
Stats	NULL
and	NULL
an	NULL
additional	NULL
homologue	NULL
(	NULL
StatSb	NULL
)	NULL
involved	NULL
in	NULL
prolactin	NULL
signal	NULL
transduction	NULL
in	NULL
mouse	NULL
mammary	NULL
tissue	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:8831-8835	NULL
.	NULL

Meier	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
nuclear	NULL
factor	NULL
YY1	NULL
participates	NULL
in	NULL
repression	NULL
of	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
and	NULL
is	NULL
counteracted	NULL
by	NULL
mammary	NULL
gland	NULL
factor	NULL
during	NULL
lactogenic	NULL
hormone	NULL
induction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:128-137	NULL
.	NULL

Mikita	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
U.	NULL
Schindler	NULL
.	NULL

1996	NULL
.	NULL

Requirements	NULL
for	NULL
interleukin-4-induced	NULL
gene	NULL
expression	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
Stat6	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:5811-5820	NULL
.	NULL

43a.Morrigl	NULL
,	NULL
R.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

Moriggl	NULL
,	NULL
R.	NULL
,	NULL
V.	NULL
Gouilleux-Gruart	NULL
,	NULL
R.	NULL
Jahne	NULL
,	NULL
S.	NULL
Berchtold	NULL
,	NULL
C.	NULL
Gartmann	NULL
,	NULL
X.	NULL
Liu	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
A.	NULL
Sotiropoulos	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
and	NULL
F.	NULL
Gouilleux	NULL
.	NULL

1996	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
carboxyl-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
MGF-Stat5	NULL
results	NULL
in	NULL
sustained	NULL
DNA	NULL
binding	NULL
and	NULL
a	NULL
dominant	NULL
negative	NULL
phenotype	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:5691-5700	NULL
.	NULL

Mosley	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
P.	NULL
Beckmann	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

March	NULL
,	NULL
R.	NULL
L.	NULL
Idzerda	NULL
,	NULL
S.	NULL
D.	NULL
Gimpel	NULL
,	NULL
T.	NULL
VandenBos	NULL
,	NULL
D.	NULL
Friend	NULL
,	NULL
A.	NULL
Alpert	NULL
,	NULL
D.	NULL
Anderson	NULL
,	NULL
J.	NULL
Jackson	NULL
,	NULL
J.	NULL
M.	NULL
Wignall	NULL
,	NULL
C.	NULL
Smith	NULL
,	NULL
B.	NULL
Gallis	NULL
,	NULL
J.	NULL
E.	NULL
Sims	NULL
,	NULL
D.	NULL
Urdal	NULL
,	NULL
M.	NULL
B.	NULL
Widmer	NULL
,	NULL
D.	NULL
Cosman	NULL
,	NULL
and	NULL
L.	NULL
S.	NULL
Park	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
murine	NULL
interleukin-4	NULL
receptor	NULL
:	NULL
molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
secreted	NULL
and	NULL
membrane	NULL
bound	NULL
forms	NULL
.	NULL

Cell	NULL
59:335-348	NULL
.	NULL

Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
S.	NULL
Sad	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
expanding	NULL
universe	NULL
of	NULL
T-cell	NULL
subsets	NULL
:	NULL
Thi	NULL
,	NULL
and	NULL
Th2	NULL
and	NULL
more	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
17:138-146	NULL
.	NULL

Mui	NULL
,	NULL
A.	NULL
L.-F.	NULL
,	NULL
H.	NULL
Wakao	NULL
,	NULL
T.	NULL
Kinoshita	NULL
,	NULL
T.	NULL
Kitamura	NULL
,	NULL
and	NULL
A.	NULL
Miyajima	NULL
.	NULL

1996	NULL
.	NULL

Suppression	NULL
of	NULL
interleukin-3-induced	NULL
gene	NULL
expression	NULL
by	NULL
a	NULL
C-terminal	NULL
truncated	NULL
Stat5	NULL
:	NULL
role	NULL
of	NULL
Stat5	NULL
in	NULL
proliferation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:2425-2433	NULL
.	NULL

Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
K.	NULL
Shimoda	NULL
,	NULL
W.	NULL
Thierfelder	NULL
,	NULL
C.	NULL
Fischer	NULL
,	NULL
A.	NULL
Kim	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
J.	NULL
L.	NULL
Cleveland	NULL
,	NULL
J.	NULL
H.	NULL
Pierce	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thle	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
of	NULL
murine	NULL
Stat6	NULL
and	NULL
human	NULL
Stat6	NULL
,	NULL
Stat	NULL
proteins	NULL
that	NULL
are	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
responses	NULL
to	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
and	NULL
IL-3	NULL
but	NULL
are	NULL
not	NULL
required	NULL
for	NULL
mitogenesis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3336-3343	NULL
.	NULL

Qureshi	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
S.	NULL
Leung	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1996	NULL
.	NULL

Function	NULL
of	NULL
Stat2	NULL
protein	NULL
in	NULL
transcriptional	NULL
activation	NULL
by	NULL
alpha	NULL
interferon	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:288-293	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

TRANSACTIVATION	NULL
DOMAINS	NULL
OF	NULL
Stat	NULL
FACTORS	NULL
3677	NULL
Raught	NULL
,	NULL
B.	NULL
,	NULL
W.	NULL
S.-L.	NULL
Liao	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Rosen	NULL
.	NULL

1995	NULL
.	NULL

Developmentally	NULL
and	NULL
hormonally	NULL
regulated	NULL
CCAAT/enhander	NULL
binding	NULL
protein	NULL
isoforms	NULL
influence	NULL
B-casein	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

9:1223-1232	NULL
.	NULL

Rippberger	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
Fritz	NULL
,	NULL
K.	NULL
Richter	NULL
,	NULL
G.	NULL
M.	NULL
Hocke	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
and	NULL
G.	NULL
H.	NULL
Fey	NULL
.	NULL

1995	NULL
.	NULL

Transcription	NULL
factors	NULL
Stat3	NULL
and	NULL
StatSb	NULL
are	NULL
present	NULL
in	NULL
rat	NULL
liver	NULL
nuclei	NULL
in	NULL
an	NULL
acute	NULL
phase	NULL
response	NULL
and	NULL
bind	NULL
interleukin	NULL
6	NULL
response	NULL
elements	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:29998-30006	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
N.	NULL
Harada	NULL
,	NULL
Y.	NULL
Nakamura	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
P.	NULL
Leland	NULL
,	NULL
M.	NULL
C.	NULL
Friedmann	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
R.	NULL
K.	NULL
Puri	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
W.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
y	NULL
chain	NULL
:	NULL
a	NULL
functional	NULL
component	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
.	NULL

Nature	NULL
262:1880-1883	NULL
.	NULL

Ryan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
L.	NULL
J.	NULL
McReynolds	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
L.~-H.	NULL
Wang	NULL
,	NULL
E.	NULL
Garfein	NULL
,	NULL
P.	NULL
Rothman	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1996	NULL
.	NULL

Growth	NULL
and	NULL
gene	NULL
expression	NULL
are	NULL
predominantly	NULL
controlled	NULL
by	NULL
distinct	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
receptor	NULL
.	NULL

Immunity	NULL
4123-132	NULL
.	NULL

Sad	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Marcotte	NULL
,	NULL
and	NULL
T.	NULL
R.	NULL
Mosmann	NULL
.	NULL

1996	NULL
.	NULL

Cytokine-induced	NULL
differentiation	NULL
of	NULL
precursor	NULL
mouse	NULL
CD8+	NULL
T	NULL
cells	NULL
secreting	NULL
Th1	NULL
or	NULL
Th2	NULL
cytokines	NULL
.	NULL

Immunity	NULL
2:271-279	NULL
.	NULL

Sadowski	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
J.	NULL
Triezenberg	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1988	NULL
.	NULL

GAL4-VP16	NULL
is	NULL
an	NULL
unusually	NULL
potent	NULL
transcriptional	NULL
activator	NULL
.	NULL

Nature	NULL
335:563-564	NULL
.	NULL

Sadowski	NULL
,	NULL
L	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
vector	NULL
for	NULL
expressing	NULL
GALA	NULL
(	NULL
1-147	NULL
)	NULL
fusions	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:7593-7599	NULL
.	NULL

Saito	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
Oka	NULL
.	NULL

1996	NULL
.	NULL

Hormonally	NULL
regulated	NULL
double-	NULL
and	NULL
single-stranded	NULL
DNA-binding	NULL
complexes	NULL
involved	NULL
in	NULL
mouse-casein	NULL
gene	NULL
transcription	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:8911-8918	NULL
.	NULL

Schaefer	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
L.	NULL
K.	NULL
Sanders	NULL
,	NULL
and	NULL
D.	NULL
Nathans	NULL
.	NULL

1995	NULL
.	NULL

Cooperative	NULL
transcriptional	NULL
activity	NULL
of	NULL
Jun	NULL
and	NULL
a	NULL
short	NULL
form	NULL
of	NULL
Stat3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:9097-9101	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
responses	NULL
to	NULL
polypep-tide	NULL
ligands	NULL
:	NULL
the	NULL
Jak-Stat	NULL
pathway	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64:621-651	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
X.-Y	NULL
.	NULL

Fu	NULL
,	NULL
T.	NULL
Improta	NULL
,	NULL
R.	NULL
Aebersold	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1992	NULL
.	NULL

Proteins	NULL
of	NULL
transcription	NULL
factor	NULL
ISGF-3	NULL
:	NULL
one	NULL
gene	NULL
encodes	NULL
the	NULL
91-	NULL
and	NULL
84-kDa	NULL
ISGF-3	NULL
proteins	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
interferon-	NULL
«	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7836-7839	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
Kashleva	NULL
,	NULL
A.	NULL
Pernis	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
and	NULL
P.	NULL
Rothmann	NULL
.	NULL

1994	NULL
.	NULL

STF-IL-4	NULL
:	NULL
a	NULL
novel	NULL
IL-4-induced	NULL
signal	NULL
transducing	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:1350-1356	NULL
.	NULL

Schindler	NULL
,	NULL
U.	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
M.	NULL
Brasseur	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1995	NULL
.	NULL

Components	NULL
of	NULL
a	NULL
Stat	NULL
recognition	NULL
code	NULL
:	NULL
evidence	NULL
for	NULL
two	NULL
layers	NULL
of	NULL
molecular	NULL
selectivity	NULL
.	NULL

Immunity	NULL
2:689-697	NULL
.	NULL

Schmitt-Ney	NULL
,	NULL
M.	NULL
,	NULL
W.	NULL
Doppler	NULL
,	NULL
R.	NULL
K.	NULL
Ball	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1991	NULL
.	NULL

Beta-casein	NULL
gene	NULL
promoter	NULL
activity	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
hormone-mediated	NULL
relief	NULL
of	NULL
transcriptional	NULL
repression	NULL
and	NULL
a	NULL
mammary-specific	NULL
nuclear	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:3745-3755	NULL
.	NULL

Schmitt-Ney	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Happ	NULL
,	NULL
R.	NULL
K.	NULL
Ball	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1992	NULL
.	NULL

Developmental	NULL
and	NULL
environmental	NULL
regulation	NULL
of	NULL
a	NULL
mammary	NULL
gland	NULL
specific	NULL
nuclear	NULL
factor	NULL
essential	NULL
for	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
beta-cascin	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:3130-3134	NULL
.	NULL

Seder	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1994	NULL
.	NULL

Acquisition	NULL
of	NULL
lymphokine-producing	NULL
phenotype	NULL
by	NULL
CD4+	NULL
T-cells	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:635-673	NULL
.	NULL

Shimoda	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Deursen	NULL
,	NULL
M.	NULL
Y.	NULL
Sangster	NULL
,	NULL
S.	NULL
R.	NULL
Sarawar	NULL
,	NULL
R.	NULL
T.	NULL
Carson	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
C.	NULL
Chu	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

A.	NULL
Vignali	NULL
,	NULL
P.	NULL
C.	NULL
Doherty	NULL
,	NULL
G.	NULL
Grosveld	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Ihle	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
IL-4-induced	NULL
Th2	NULL
response	NULL
and	NULL
IgE	NULL
class	NULL
switching	NULL
in	NULL
mice	NULL
with	NULL
disrupted	NULL
Stat6	NULL
gene	NULL
.	NULL

Nature	NULL
380:630-633	NULL
.	NULL

Standke	NULL
,	NULL
G.	NULL
J.	NULL
R.	NULL
,	NULL
V.	NULL
S.	NULL
Meier	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1994	NULL
.	NULL

Mammary	NULL
gland	NULL
factor	NULL
activated	NULL
by	NULL
prolactin	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
and	NULL
acute-phase	NULL
response	NULL
factor	NULL
activated	NULL
by	NULL
IL-6	NULL
in	NULL
liver	NULL
cells	NULL
are	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
potential	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

8:469-477	NULL
.	NULL

Stocklin	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Wissler	NULL
,	NULL
F.	NULL
Gouilleux	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
interactions	NULL
between	NULL
Stats	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Nature	NULL
383:726-728	NULL
.	NULL

Takeda	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
W.	NULL
Shi	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
M.	NULL
Minami	NULL
,	NULL
S.	NULL
Kashi-wamura	NULL
,	NULL
K.	NULL
Nakanishi	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1996	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
IL-4	NULL
signalling	NULL
.	NULL

Nature	NULL
380:627-630	NULL
.	NULL

Tepper	NULL
,	NULL
R.	NULL
L	NULL
,	NULL
D.	NULL
A.	NULL
Levinson	NULL
,	NULL
B	NULL
.	NULL

Z.	NULL
Stanger	NULL
,	NULL
J.	NULL
Campos-Torres	NULL
,	NULL
A.	NULL
K.	NULL
Abbas	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1990	NULL
.	NULL

IL-4	NULL
induces	NULL
allergic-like	NULL
inflammatory	NULL
disease	NULL
and	NULL
alters	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
62:457-467	NULL
.	NULL

Wakao	NULL
,	NULL
H.	NULL
,	NULL
F.	NULL
Gouilleux	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1994	NULL
.	NULL

Mammary	NULL
gland	NULL
factor	NULL
(	NULL
MGF	NULL
)	NULL
is	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
cytokine	NULL
regulated	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
and	NULL
confers	NULL
the	NULL
PRL	NULL
response	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:2182-2191	NULL
.	NULL

Wang	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Keegan	NULL
.	NULL

1996	NULL
.	NULL

IL-4	NULL
function	NULL
can	NULL
be	NULL
transferred	NULL
to	NULL
the	NULL
IL-2	NULL
receptor	NULL
by	NULL
tyrosine	NULL
containing	NULL
sequences	NULL
found	NULL
in	NULL
the	NULL
IL-4	NULL
receptor	NULL
«	NULL
chain	NULL
.	NULL

Immunity	NULL
4:113-121	NULL
.	NULL

Wartmann	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Cella	NULL
,	NULL
P.	NULL
Hofer	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
X.	NULL
Liu	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
and	NULL
N.	NULL
E.	NULL
Hynes	NULL
.	NULL

1996	NULL
.	NULL

Lactogenic	NULL
hormone	NULL
activation	NULL
of	NULL
Stat5	NULL
and	NULL
transcription	NULL
of	NULL
the	NULL
beta-casein	NULL
gene	NULL
in	NULL
mammary	NULL
epithelial	NULL
cells	NULL
is	NULL
independent	NULL
of	NULL
p42	NULL
MAP	NULL
kinase	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:31863-31868	NULL
.	NULL

Wen	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Zhong	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

Maximal	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
Statl	NULL
and	NULL
Stat3	NULL
requires	NULL
both	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
82:241-250	NULL
.	NULL

Wery	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Letourneur	NULL
,	NULL
J.	NULL
Bertoglio	NULL
,	NULL
and	NULL
J.	NULL
Pierre	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-4	NULL
induces	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
and	NULL
phosphorylation	NULL
of	NULL
she	NULL
in	NULL
human	NULL
keratinocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:8529-8532	NULL
.	NULL

3678	NULL
76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

MORIGGL	NULL
ET	NULL
AL	NULL
.	NULL

Yan	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Small	NULL
,	NULL
C.	NULL
Desplan	NULL
,	NULL
C.	NULL
R.	NULL
Dearolf	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
Stat	NULL
gene	NULL
that	NULL
functions	NULL
in	NULL
Drosophila	NULL
development	NULL
.	NULL

Cell	NULL
84:421-430	NULL
.	NULL

Yoshimura	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Ichibara	NULL
,	NULL
I.	NULL
Kinjyo	NULL
,	NULL
M.	NULL
Moriyama	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
D.	NULL
J.	NULL
Gilbert	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
T.	NULL
Hara	NULL
,	NULL
and	NULL
A.	NULL
Miyajima	NULL
.	NULL

1996	NULL
.	NULL

Mouse	NULL
oncostatin	NULL
M	NULL
:	NULL
an	NULL
immediate	NULL
carly	NULL
gene	NULL
induced	NULL
by	NULL
multiple	NULL
cytokines	NULL
through	NULL
the	NULL
JAK-STATS	NULL
pathway	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:1055-1063	NULL
.	NULL

Yoshimura	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Ohkubo	NULL
,	NULL
T.	NULL
Kiguchi	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
D.	NULL
J.	NULL
Gilbert	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
T.	NULL
Hara	NULL
,	NULL
and	NULL
A.	NULL
Miyajima	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
cytokine	NULL
inducible	NULL
gene	NULL
79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

CIS	NULL
encodes	NULL
an	NULL
SH2-containing	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
tyrosine	NULL
phosphorylated	NULL
interleukin	NULL
3	NULL
and	NULL
erythropoietin	NULL
receptors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2816-2826	NULL
.	NULL

Yu-Lee	NULL
,	NULL
L.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hrachovy	NULL
,	NULL
A.	NULL
M.	NULL
Stevens	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Schwarz	NULL
.	NULL

1990	NULL
.	NULL

Inter-feron-regulatory	NULL
factor	NULL
1	NULL
is	NULL
an	NULL
immediate-early	NULL
gene	NULL
under	NULL
transcriptional	NULL
regulation	NULL
by	NULL
prolactin	NULL
in	NULL
Nb2	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3087-3094	NULL
.	NULL

Zhang	NULL
,	NULL
X.	NULL
,	NULL
J.	NULL
Blenis	NULL
,	NULL
H.-C.	NULL
Li	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
and	NULL
S.	NULL
Chen-Kiang	NULL
.	NULL

1995	NULL
.	NULL

Requirement	NULL
of	NULL
serine	NULL
phosphorylation	NULL
for	NULL
formation	NULL
of	NULL
Stat-promoter	NULL
complexes	NULL
.	NULL

Science	NULL
267:1990-1994	NULL
.	NULL

Zimmermann	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
Morigg	NULL
!	NULL

.	NULL

Unpublished	NULL
data	NULL
.	NULL

